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ABSTRACT

Bauer, Amy E. Ph.D., Purdue University, December 2015. The Epidemiology of Coxiella
burnetii in Goats in Indiana. Major Professor: George E. Moore.

Coxiella burnetii is an obligate, intracellular bacterium and the etiologic agent of
the zoonotic disease Q fever. Through the presence of an environmentally resilient small
cell variant, C. burnetii can persist outside of a host in the face of extremes in
temperature, humidity, and pressure. C. burnetii is considered to be ubiquitous in the
environment and endemic in cattle, sheep and goat populations. These same species
are the main reservoirs for human infection with C. burnetii. The overall goal of this
project was to develop a baseline understanding of the epidemiology of C. burnetii in
goats in Indiana. Specific areas addressed were: Individual and herd level prevalence of
infection with C. burnetii as evaluated by serologic and molecular methods, geographic
distribution of individuals and herds positive for infection with C. burnetii, and
evaluation of potential risk factors for infection with C. burnetii among individual goats
and herds. Six-hundred-fifty-four does representing 95 herds were included in the study
sample as a whole. Six-hundred-forty-nine of the does from 94 farms were from Indiana.
Based on the use of a commercial enzyme-linked immunosorbent assay (ELISA), there
was a 3.8% estimated individual level and 11.2% estimated herd level seroprevalence

xi
for C. burnetii in Indiana. Through use of a real-time polymerase chain reaction (PCR)
assay targeting the IS1111 transposon of C. burnetii in DNA samples from either milk,
vaginal mucus samples or feces, there was a 7.5% estimated prevalence of shedding C.
burnetii at the individual level and a 20.2% estimated prevalence of shedding C. burnetii
DNA at the herd level. There was no statistically significant difference detected between
regions of Indiana in regards to does testing positive for C. burnetii. However, a
statistically significant association was detected between does testing positive for C.
burnetii and the Public Health Preparedness District (PHPD) of Indiana in which the farm
was located. Finally, 3 potential risk factors of interest: The presence of cattle, sheep or
camelids on the farm; history of abortion, stillbirth or weak offspring within the herd;
and whether or not the goats were housed primarily indoors were evaluated for
associations with seropositivity for or shedding of C. burnetii. Of these 3 factors, only
the presence of cattle, sheep or camelids on the farm demonstrated a statistically
significant association with the likelihood of detecting either anti-C. burnetii antibodies
or shedding of C. burnetii DNA. Rather than increasing the likelihood of detecting C.
burnetii, the presence of these other species on the farm appears to have a protective
effect.
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CHAPTER 1.

INTRODUCTION

Coxiella burnetii is the causative agent of Q fever, a disease that has varying
manifestations among and within species, some of which can be both life threatening
and emotionally devastating. With a low infectious dose and transmission through
inhalation of aerosols, C. burnetii has been researched as a potential bioweapon and is
currently a Class B bioterror agent (Oyston & Davies, 2011). Working with the live agent
requires Biosafety Level 3 precautions. Although precautions should be taken when
working with C. burnetii in a laboratory setting, it is presumed to be endemic in cattle,
sheep and goats worldwide and ubiquitous in the environment. Indeed the presence of
C. burnetii has been documented in environmental dust samples from post offices, high
schools and grocery stores based upon the detection of the insertion sequence 1111
transposon (IS1111) by quantitative polymerase chain reaction (PCR) (Kersh et al, 2010).
Q fever has been a reportable disease in the United States since 1999 (McQuiston
et al., 2006) and is reportable in both people and animals in Indiana. The Centers for
Disease Control and Prevention (CDC) reported an increasing trend in the diagnosis of Q
fever in the United States between 2000 and 2007 with a range from 17 to 167 cases

2
reported annually (CDC, 2013). A study conducted between 2003 and 2004 tested 4,437
people for anti-C. burnetii antibodies and estimated a national seroprevalence of 3.1%
(Anderson et al, 2009). The incidence rate for Q fever between 2000 and 2012 was 0.38
cases per million people per annum (Dahlgren et al, 2015). In Indiana, a peak number of
human Q fever cases occurred in 2005 with 4 cases reported to the Indiana State
Department of Health (Beall et al., 2007).
The presence of C. burnetii in cattle from Indiana has been documented in studies
at the national level (Kim et al, 2005; APHIS, 2011). Of 316 bulk tank milk samples from
commercial cattle dairies collected by the Indiana State Board of Animal Health in 2011,
193 (60.8%) tested positive for the presence of the IS1111 transposon of C. burnetii
(Bauer et al, 2015). Cattle are only 1 of the host species capable of transmitting C.
burnetii to people. Sheep and goats are also reservoir species for C. burnetii (Norlander,
2000). In recent years, goats have been more likely to be reported as the source of
human outbreaks of Q fever (Bamberg et al., 2007; Schimmer et al. 2010; Bjork et al.,
2014).
The overarching goal of the studies reported herein was develop a baseline
understanding of the epidemiology of C. burnetii in goats in Indiana. The studies
reported in the following chapters do not seek to completely define the epidemiology of
C. burnetii in Indiana, but rather to lay a foundation for future work that enhances the
understanding of the role of goats in the epidemiology, ecology, and public health of C.
burnetii and Q fever.
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CHAPTER 2.

2.1

LITERATURE REVIEW

Taxonomy of Coxiella burnetii

Coxiella burnetii is a small, gram negative, intracellular coccobacillus (Oyston &
Davies, 2011). It is taxonomically classified in the phylum Proteobacteria, class
Gammaproteobacteria and order Legionellales which it shares with the family
Legionellaceae. In addition to Coxiella, the Coxiellaceae family includes the genera
Rickettsiella, Diplorickettsia, and Aquicella (Drancourt & Raoult, 2005). A second
proposed species, Coxiella cheraxi, has been identified in freshwater crayfish (Tan &
Owens, 2000). In addition to C. burnetii and C. cheraxi, Coxiella-like endosymbionts have
been documented in several species of ticks (Klyachko et al., 2007; Liu et al., 2013;
Wilkinson et al., 2014), though species status has not yet been proposed for these
organisms.
Prior to 2009 and the development of specialized media mimicking the
intracellular environment in which it reproduces, C. burnetii was not able to be cultured
in vitro (Omsland et al., 2009). Because of this, identification of different strains of C.
burnetii has been based on molecular techniques. Several methods have been utilized to
define genotypes of C. burnetii. Historically these included restriction length fragment
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polymorphism analysis (RFLP) (Jager et al., 1998), plasmid typing and comparison of the
molecular sequences of highly conserved genes such as com-1, which codes for an outer
membrane protein (Hendrix et al., 1993), and isocitrate dehydrogenase (icd) (Massung
et al., 2012). More recently, high resolution techniques have been developed including:
Multilocus variable tandem number repeat analysis (MLVA) (Roest et al., 2011),
multispacer sequence typing (MST) (Glazunova et al., 2005), and whole genome
comparisons based upon microarray technology (Massung et al., 2012).
RFLP analysis is based upon differences in patterns in bands when viewing gel
electrophoresis or Southern blot products. Restriction enzymes targeting specific
nucleotides at each end of the sequence of interest are used to cut DNA into fragments.
Changes in the target sequence will change the size and number of the fragments,
resulting in different patterns of banding on agarose gel electrophoresis (Tang et al,
1997; Jager et al., 1998). Utilizing PCR-RFLP, Nguyen and Hirai were able to divide 19
isolates of C. burnetii into 3 groups. Isolates from acute Q fever patients clustered with
samples from cattle and isolates from chronic Q fever patients clustered with a sample
from a goat with an aborted pregnancy (Nguyen & Hirai, 1999).
Plasmid typing of C. burnetii focuses on the 5 types of plasmids identified in
various C. burnetii genomes. Four of these are true plasmids (QpDG, QpDV, QpH1 and
QpRS) and one is a plasmid-homologous sequence incorporated into the chromosome
(Massung et al., 2012). These 5 plasmids defined 5 different genomic groups of C.
burnetii, some having specific geographic associations (Massung et al., 2012).
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Highly conserved genes may display random sequence variations that can be
utilized for genotyping. The com-1 and icd genes are most commonly chosen for this
type of analysis. Com-1 codes for an outer membrane protein (Hendrix et al., 1993).
Four to 5 different genogroups have been identified based on analyses of variation in
the com-1 sequence (Zhang et al, 1997; Massung et al., 2012). Icd codes for a dimeric
NADP(+)-dependent isocitrate dehydrogenase similar to that of E. coli and S. enterica,
but is preferentially expressed at a low pH such as that favored by C. burnetii (Nguyen et
al., 1999). Based on icd analysis, 3 different genogroups of C. burnetii have been
identified (Massung et al., 2012). Poor discriminatory power has resulted in the
abandonment of these methods of genotyping (Massung et al., 2012) although these
genes are still used in diagnostic PCR.
MLVA is based upon calculating the number of small repeats within a target
region or regions of a bacterial genome. MLVA has a high discriminatory power, but
there are challenges in defining the most common sequence pattern (consensus
sequence) for reference between laboratories (Massung et al., 2012). Nevertheless,
MLVA has been frequently used to identify genotypes of C. burnetii (Arricau-Bouvery et
al., 2006, Boarbi et al., 2014, Frangoulidis et al., 2014).
MST identifies genetic sequences, 300 to 700 base pairs in length, positioned
between coding regions of the genome. In comparison to MLVA, MST analysis has a
lower discriminatory power but MST results are more easily compared between groups
(Massung et al., 2012). Using MST, 30 different sequence types (ST) of C. burnetii were
initially described and STs 8, 16, 20 and 21 were identified in samples from the United

8
States (Glazunova et al., 2005). In addition to geographic trends, STs 1, 4, 16 and 18
were associated with human patients that presented with acute Q fever and ST8 was
associated with human patients presenting with chronic Q fever (Glazunova et al., 2005).
As application of MST has continued, additional sequence types have been identified,
including a novel form from French Guiana, ST17, which may have the 3-toed sloth as its
primary reservoir (Mahamat et al., 2013, Davoust et al., 2014). This strain is associated
with a particularly severe form of acute Q fever with a higher prevalence of pneumonia
in infected patients when compared with acute Q fever patients in France (Edouard et
al., 2014). A single nucleotide polymorphism (SNP) analysis has been developed to
differentiate between MST sequence types (STs) of C. burnetii (Hornstra et al., 2011).
SNP analysis targets a change in nucleotide at a single site in the genetic region of
interest. Utilizing this analysis, ST8 was identified as the most common ST in goat milk in
the United States, although ST20 was also present in some samples (Pearson et al.,
2014).
2.2

Lifecycle of Coxiella burnetii

C. burnetii has a complex lifecycle involving an intracellular, metabolically active
form called the large cell variant (LCV) and two apparently metabolically inactive forms
that are resilient enough to survive in the environment called the small cell variant (SCV)
and small dense cell (SDC) (Norlander, 2000). Large cell variants may also contain polar
endospore-like structures, the role of which is unknown (Heinzen et al., 1999; Minnick &
Raghavan, 2012). These are not considered to be true endospores because the C.
burnetii genome does not contain the genes normally associated with sporulation and
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does not produce dipicolinic acid (Minnick & Raghavan, 2012). In Bacillus subtilis spores,
the presence of dipicolinic acid is associated with resistance to damage from wet heat
and protection of DNA from damage due to light, dry heat and desiccation (Setlow et al.,
2006). The SDC is a laboratory observed variant of the SCV that is produced when C.
burnetii is treated with pressure in excess of 20,000 pounds per square inch (Minnick &
Raghavan, 2012). The resilient, metabolically inactive SCV is the infectious form of C.
burnetii and allows the organism to persist in a contaminated environment, leading to
increased exposure of susceptible hosts to the bacterium.
Differences in the physical structure and protein expression between the SCV
and LCV can be related to different requirements for environmental resilience as
compared to active metabolism and reproduction. The SCV is, as its name implies, the
smaller of the two forms, measuring approximately 0.2-0.5m. The genetic material in
the SCV is condensed and an intracellular membrane system is also present. LCVs are
greater than 1m in length and pleomorphic with dispersed genetic material. Aside
from physical differences, certain proteins are differentially expressed in the SCV and
the LCV (Minnik and Raghaven, 2012). Minnik and Raghavan refer to these as
SCVHi/LCVLo and LCVHi/SCVLo respectively. SCVHi/LCVLo proteins are important promotors
of cell differentiation, substrate uptake, and condensation of genetic material (Minnick
& Raghavan, 2012). LCVHi/SCVLo proteins include those that promote translation, help to
mediate the environmental challenges of replicating in a highly acidic environment,
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manage transcription and aid both DNA replication and cell division. Both groups
contain proteins that maintain biosynthetic pathways (Minnick & Raghavan, 2012).
In addition to the SCV and LCV, two phases of C. burnetii exist based upon the
lipopolysaccharide content of the cell wall. Phase I bacteria have a complete
lipopolysaccharide surface while phase II bacteria have a truncated lipopolysaccharide
lacking the O antigen (Voth & Heinzen, 2007; Oyston & Davies, 2011). The genes coding
for this antigen may in fact be absent in some phase II C. burnetii. Phase II bacteria are
generally not identified in vivo, but develop after serial passages in tissue culture or
embryonated eggs (Voth & Heinzen, 2007; Oyston & Davies, 2011). It was initially
hypothesized that the phase of the bacteria related to the form of clinical disease such
that infection with phase I bacteria resulted in acute Q fever while infection with phase
II resulted in the chronic form, but this model is not currently accepted (Heinzen et al.,
1999). Rather, phase I bacteria are the virulent form of C. burnetii while phase II bacteria
are avirulent in immunocompetent individuals (Voth & Heinzen, 2007; Shannon &
Heinzen, 2009).
Once inhaled or ingested by the host, the phase I SCV preferentially targets
macrophages, particularly in the lung and liver. The complete phase I LPS likely acts to
hide surface antigens from pattern recognition receptors on dendritic cells (Shannon &
Heinzen, 2009). Lack of dendritic cell response to C. burnetii affects the response of
macrophages to the organism. Rather than expressing M1 polarization, a microbicidal
response, macrophages instead respond to phase I C. burnetii with M2 polarization. This
results in a lower rate of phagocytosis and lack of microbicidal activity (Ben Amara et al.,
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2012). Phase I C. burnetii uptake by TLR4 in M2 macrophages involves only the v3
integrin which leads to cytoskeletal reorganization. This reorganization results in cell
spreading and the formation of filopodia and lamellopodia by the macrophages due to
underlying localization of F-actin (Honstettre et al., 2004). Uptake of phase II C. burnetii,
where dendritic cells are activated and macrophages produce an M1 response, is
mediated by both v3 and CR3 integrins and produces a greater rate of phagocytosis
(Ben Amara et al., 2012). Indeed, when phagocytosis indices (PI) of C. burnetii with
phase I LPS were compared between wild type and TLR4 deficient mice, the TLR4
deficient mice had a lower mean PI than the wild type mice (Honstettre et al., 2004). PIs
were also compared between phase I and phase II C. burnetii. Phagocytosis indices were
greater for C. burnetii with phase II LPS as compared to C. burnetii with phase I LPS, but
there was not a statistically significant difference in these measures between wild type
and TLR4 deficient mice for phase II LPS (Honstettre et al., 2004). The role LPS plays in
inhibition of the uptake of C. burnetii was also evaluated in this study. When polymyxin
B was used to block binding of LPS by monocytes in vitro, organisms exhibiting phase I
LPS were blocked from uptake, while those exhibiting phase II LPS were not blocked
(Honstettre et al., 2004). Thus, the complete phase I LPS appears to aid C. burnetii in
inhibiting the immune response without completely suppressing the phagocytic process
necessary for its incorporation into macrophages for replication.
After phagocytosis, C. burnetii stalls the maturation of the phagosome for
approximately 2 hours. A second virulence factor, the type IV Dot/ICM secretion system
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(T4SS) is translocated about 8 hours after phagocytosis (van Schaik et al., 2013). Type IV
secretion systems help to control the development of infection over time and the C.
burnetii T4SS potentially utilizes 22 different effectors to promote infection and
replication (van Schaik et al., 2013). These effectors localize to sites such as the Golgi
apparatus, the nucleus, the autophagosome and the mitochondrion and may be
involved in how C. burnetii controls the secretory pathway, transcription and apoptosis
in the host cell (van Schaik et al., 2013). Over a 1 to 2 day lag period, the SCV of C.
burnetii transform to LCV and the phagosome becomes an early parasitophorous
vacuole (PV) with a cholesterol-rich plasma membrane and an internal pH of 4.5-5
(Howe & Heinzen, 2005; Minnick & Raghavan, 2012; Gilk, 2012). The large cell variants
then divide by binary fission during a log phase of growth (Ghigo et al., 2012).
Approximately 4-6 days postinfection, the PV contains extensive numbers of LCVs, and
enters the stationary phase of replication. The LCVs begin to transition back to SCVs
during this phase (Voth & Heinzen, 2007). In tissue culture, rupture of the PV and the
cell in which it has become the dominant structure at approximately 12-16 days postinfection releases the SCVs (Minnick & Raghavan, 2012). Because C. burnetii can exert
control over apoptosis, not all of the infected cells rupture. In fact, infected cells can
divide such that the PV is localized into a single daughter cell (Minnick & Raghavan,
2012).
Replication of C. burnetii cannot occur without the formation of a PV. Inhibition
of cholesterol metabolism by agents such as ketoconazole, imipramine and
progesterone has been demonstrated to disrupt PV formation through altered
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cholesterol metabolism (Howe & Heinzen, 2005). These agents do not act uniquely on
the cholesterol biosynthetic pathway, but rather affect general sterol production,
clouding the importance of cholesterol specifically for C. burnetii replication as
compared to sterols in general (Gilk, 2012). Future treatments for Q fever may focus on
the inhibition of cholesterol metabolism and other methods to block PV formation.
Although C. burnetii makes use of the phagolysosome within macrophages for
replication, the immune system is not completely deceived by the pathogen and both
cell-mediated and humoral immune responses to infection occur. Lymphocyte
production of interferon gamma leads to recruitment of fibroblasts, additional
macrophages, and monocytes as well as the production of reactive oxygen and nitrogen
species (Shannon & Heinzen, 2009). T-cells play a role in controlling acute C. burnetii
infection, but at this time the specific type of T-cell involved in the cell-mediated
response is undetermined (Shannon & Heinzen, 2009). There is some evidence that
regulatory T-cells may play a role in the persistence of C. burnetii within the body and
thus the development of the chronic form of Q fever (Ben Amara et al., 2012). The
humoral response to acute infection by C. burnetii, characterized by high levels of
antibody responding to the phase II LPS, occurs within 3 to 4 weeks of the development
of clinical signs (Shannon & Heinzen, 2009). Antibody opsonization of phase I C. burnetii
appears to increase phagocytosis by macrophages, but does not affect intracellular
growth; in contrast, opsonized phase II C. burnetii stimulate maturation and production
of inflammatory cytokines by dendritic cells (Shannon & Heinzen, 2009).
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The immune response in chronic C. burnetii infection has been associated with
increased levels of interleukin-10 (IL-10) (Shannon & Heinzen, 2009). These increased
levels may be related to immunosuppression in the chronic form of Q fever (Capo &
Mege, 2012). Interestingly, IL-10 may also play a role in the observed higher level of Q
fever diagnosis in men as compared to women. In evaluating gene modulation in C.
burnetii infected mice, 60% of the observed modulations were related to sex hormones
with the modulation expressed to greater degree in males than in females. IL-10 genes
are among those upregulated in males (Capo & Mege, 2012).
2.3

Transmission of Coxiella burnetii

C. burnetii transmission has been documented to occur by four routes:
Inhalation, ingestion, sexual contact and tick bite. The most important of these routes
for human and domestic animal disease is inhalation. Ingestion of C. burnetii,
particularly through consumption of unpasteurized milk, is of public health concern, but
the magnitude of this concern is debatable. Sexual transmission has been reported in
the spouses of military servicemen returning from the Middle East to the United States
(Miceli et al., 2012) and the potential for transmission in embryo transfer materials has
also been studied (Alsaleh et al., 2011). Transmission by tick bite is believed to play an
important role in maintaining circulation of C. burnetii in wildlife populations, but
further research is needed to clarify the role of arthropod vectors in domestic animals
and people.
Inhalation is the most important route for transmission of C. burnetii. Organismal
DNA has been identified in particles small enough for inhalation (Hogerwerf et al., 2012).
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Inhalable dust samples (particulate size 50% cutoff of 30m) were captured in glass
fiber filters with a diameter of 37mm and smaller, PM10 particles (diameters of 10m or
less) were captured using Teflon filters with a 2.0m pore size at farms where goats had
been culled due to a Q fever outbreak. C. burnetii was identified in both the PM 10 and
the larger, inhalable particles. The percentage of airborne particles positive for C.
burnetii was greater in samples collected during periods of activity on the farms. Settled
dust samples were also collected and 13 of the 14 collected samples were positive for
the presence of C. burnetii (Hogerwerf et al., 2012). C. burnetii was also found to persist
in air samples taken 1 year after an outbreak of Q fever abortion in goats (Kersh et al.,
2013), indicating that while resolution of clinical disease may reduce the risk of
transmission of C. burnetii, the risk is not eliminated.
Transmission of C. burnetii through ingestion has been a concern almost since
the discovery of the organism. Although pasteurization was initially developed to help
control brucellosis, the recommended temperature settings were developed to
inactivate C. burnetii (Cerf & Condron, 2006). Milk is the main route of shedding of C.
burnetii in dairy cattle (Rodolakis et al., 2007), and prevalence estimates of herds
shedding C. burnetii in milk are high (Kim et al., 2005; APHIS, 2011). Outbreaks of C.
burnetii have been linked to consumption of unpasteurized dairy products (Fishbein &
Raoult, 1992; Signs et al., 2012). However there is debate as to the epidemiologic
importance of the oral route of transmission and indeed whether C. burnetii should be
considered to be a food-borne pathogen (Cerf & Condron, 2006; Gale et al., 2015).
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Sexual and reproductive contacts are also potential routes of transmission of C.
burnetii. In humans, cases of Q fever have been linked to sexual activity (Miceli et al.,
2012) as well as childbirth (Raoult & Stein, 1994). C. burnetii has been identified in bull
semen (Kruszewska & Tylewska-Wierzbanowska, 1997). Embryo transfer has also been
identified as a potential route of C. burnetii transmission in domestic ruminants. C.
burnetii DNA was identified in 8/20 sample of flushing media collected from caprine
reproductive tracts in a simulation of the embryo harvesting process (Alsaleh et al.,
2011). More work is needed to evaluate artificial insemination and embryo transfer as
routes of C. burnetii transmission between conspecifics, but there is certainly the
potential for organism transfer by these routes.
Finally, tick bites are considered to be a route of C. burnetii transmission, though
this is likely more important in wildlife than in people. Experimental work has
documented transmission of C. burnetii to guinea pigs by tick bite (Smith, 1941), but
there have been few case reports of Q fever linked to ticks. A case reported in 1947
reported interactions with ticks, “Ticks were numerous and those removed from his
clothes were destroyed by being crushed with his fingers,” but no bites (Eklund et al.,
1947). A study of 400 confirmed cases of Q fever identified concurrent infection with
other known tick-borne pathogens in 6 individuals, 3 of which were believed to be due
to simultaneous infection after a tick bite (Rolain et al., 2005). While ticks should not be
ruled out as a reservoir for C. burnetii in wildlife and domestic animals, their role in the
spread of C. burnetii to people is likely secondary to that of other routes of transmission.

17
Close association with infected individuals or products from infected animals is
not necessary for exposure to C. burnetii. Wind can carry the bacteria away from the
original infected location (Tissot-Dupont et al., 1999,; Tissot-Dupont et al., 2004;
Arricau-Bouvery & Rodolakis, 2005; van der Hoek et al., 2010; Smit et al., 2012). Indeed,
windborne transmission of C. burnetii from farms experiencing abortion storms has
been identified as a factor in the largest modern outbreak of human Q fever (Schimmer
et al., 2010) as well as smaller outbreaks (Tissot-Dupont et al., 1999). In a populationbased study in the Netherlands, the presence of greater than 2,250 goats within 5km of
a residence was associated with an increased odds of diagnosis of “other infectious
disease”, a morbidity classification which is defined as Lyme disease or Q fever in the
Netherlands (Smit et al., 2012). The odds of diagnosis with “other infectious disease”
increased with animal density, with people living within 5km of 2,251-7,250 goats
demonstrating a 2-fold increase in the odds of this diagnosis, those living within 5km of
7,251-17,190 goats demonstrating a 4 fold increase in the odds of this diagnosis and
those living within 5km of 17,191-20,960 goats demonstrating a 12-fold increase in the
odds of this diagnosis when compared with individuals living within 5km of 2,250 or
fewer goats (Smit et al., 2012). Dry conditions also appear to be linked with an increased
incidence of clinical disease (Tissot-Dupont et al., 1999; Tissot-Dupont et al., 2004; van
der Hoek et al., 2010). The presence of C. burnetii has been documented in locations
where the presence of animals would not be expected such as high schools, banks and
post offices. Environmental dust samples were collected by HEPA vacuum, sponge or
swab wipes from solid surfaces or by collecting 10-50g of ground material (soil). At some
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sites, up to 50% of the samples tested demonstrated the presence of C. burnetii DNA
(Kersh et al., 2010). The ubiquity of C. burnetii becomes important when considered in
its context as a potential bioweapon (Oyston & Davies, 2011). Knowledge of the
prevalence and strains of C. burnetii naturally circulating within ruminant populations
and present in the environment is an important consideration in differentiating natural
outbreaks from biological attacks.
2.4

Coxiella burnetii host species

Small ruminants are the main reservoir species for human infection with C.
burnetii (Hugh-Jones et al., 1995; Rodolakis et al., 2007). This may be due to the
importance of bacterial shedding in feces and urine in these species, which result in
greater contamination of the environment (Arricau-Bouvery & Rodolakis, 2005).
Alternately, the strain(s) of C. burnetii infecting small ruminants may be more virulent,
leading to a larger number of Q fever diagnoses related to the these species as
compared to cattle.
C. burnetii is considered to be enzootic in all domestic ruminants in the United
States and ubiquitous worldwide with the apparent exception of New Zealand
(McQuiston et al., 2006; Hilbink et al., 1993; Greenslade et al., 2003). There may be no
manifestation of disease in cattle, sheep or goats. However, abortion, stillbirth and weak
offspring can result from infection in all of these species. When abortion or stillbirth
occurs, C. burnetii is shed in great numbers in the placenta and reproductive discharges,
contaminating the environment (Norlander, 2000; Oyston & Davies, 2011). Fecal and
urine shedding have been documented in sheep and goats and are important routes of
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shedding and sources of environmental contamination in some species (Arricau-Bouvery
& Rodolakis, 2005; Oyston & Davies, 2011). C. burnetii is also shed in milk, particularly
by cattle and goats, and the possibility of transmission through ingestion of
unpasteurized milk products is present (Fishbein & Raoult, 1992; Rodolakis et al., 2007;
Arricau-Bouvery et al., 2003).
In addition to cattle, sheep and goats, multiple species, across several taxa, are
able to become infected with and transmit C. burnetii. Among domestic species, both
the domestic cat (Pinsky et al., 1991) and the domestic dog (Buhariwalla et al., 1996)
have been associated with outbreaks of Q fever. C. burnetii has also been identified in
chickens, quail and domestic waterfowl (To et al., 1998) as well as the domestic camel
(Rahimi et al., 2011; Mohammed et al., 2014).
Infection with C. burnetii has been investigated in wildlife species closely
associated with human beings. Pigeons were implicated in a French outbreak of Q fever
(Stein & Raoult, 1999). Seropositivity for C. burnetii has been documented in wild rats in
India (Yadav et al., 1979), the United Kingdom (Webster et al., 1995) and the
Netherlands (Reusken et al., 2011). A 2011 review identified worldwide reports of
seropositivity for exposure to C. burnetii in 7 species of rat and 9 species of mouse.
Isolation of C. burnetii was reported in 4 species of rat and 4 species of mouse. The
isolation studies were all published prior to 1980, thus modern molecular techniques
were not employed (Meerburg & Reusken, 2011).
Numerous wildlife species that are not generally associated with people have
also been documented as hosts of C. burnetii. Prevalence estimates have been made for
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multiple species of deer and moose in various geographic regions (Marrie et al., 1993;
Rijks et al., 2011; Ohlson et al., 2014; Shin et al., 2014,). For deer species,
seroprevalence ranged from 1.5% in white tailed deer in Nova Scotia (Marrie et al., 1993)
to 9.2% in Korean water deer (Shin et al., 2014). Detection of C. burnetii DNA in deer
ranged from 6.6% in Korean water deer (Shin et al., 2014) to 23% in roe deer in the
Netherlands (Rijks et al., 2011). It is of note that the latter study was conducted during
an outbreak of Q fever in dairy goats and people (Rijks et al., 2011). In moose, no
seropositive individuals were detected among 99 sampled in Sweden (Ohlson et al.,
2014) while 16.5% of the individuals sampled in Nova Scotia had detectable antibodies
(Marrie et al., 1993). Marsupials are also known to be hosts for C. burnetii (Bennett et al.,
2011; Cooper et al., 2012) although there have not been reports linking these species to
human infection. Conversely, the three-toed sloth has been proposed as the reservoir
species for a strain of C. burnetii that caused severe Q fever in French Guiana (Davoust
et al., 2014). Infection with C. burnetii has also been reported in marine mammals
(Kersh et al., 2010) and the environment of their calving grounds (Duncan et al., 2012).
This raises the concern of transmission of C. burnetii to individuals harvesting and
consuming the meat of marine mammals, but at this time there have been no reports of
transmission by this route (Tryland et al., 2014).
Ticks have been well documented to carry both C. burnetii and Coxiella-like
symbiotes. Species of ticks documented as carriers of Coxiella include Amblyomma
americanum and Dermacentor silvarum (Klyachko et al.; 2007, Liu et al., 2013). Ticks are
believed to maintain infection with C. burnetii in wildlife species, but given the
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challenges of working with C. burnetii, this hypothesis has mostly been explored through
observational studies involving collecting ticks and using molecular techniques to
identify the symbiotic microbes (Klyachko et al., 2007; Liu et al., 2013).
2.5

Q fever: Clinical disease and outbreaks

Q fever is the clinical form of infection with C. burnetii, although the term
coxiellosis has also been used for clinical infection in non-human species. It is assumed
that the majority of C. burnetii infections in animals are asymptomatic. Among the
domestic ruminant reservoirs of C. burnetii, the clinical presentation of Q fever can vary
by species. Abortion and stillbirth due to C. burnetii have been reported to occur in
cattle, but there has been no experimental confirmation of causality (Garcia-Ispierto et
al., 2014). Similarly, retained placenta, mastitis, metritis and endometritis have all been
linked to infection with C. burnetii in cattle, but evidence to support these associations is
lacking (Garcia-Ispierto et al., 2014). In comparison to cattle, small ruminants,
particularly goats, are more likely to exhibit reproductive effects from C. burnetii
infection, including late term abortion, stillbirth or weak kids (Arricau-Bouvery &
Rodolakis, 2005). In experimental infection of 12 goats by subcutaneous injection at 90
days of pregnancy, mild hepatitis and interstitial pneumonia were identified in 2 does
sacrificed at days 26 and 40 after infection but prior to abortion (Sanchez et al., 2006).
Inflammatory changes were also identified in the mammary gland of 1 of 2 does
sacrificed on day 40. The remaining infected does all aborted, but no pathology was
identified in organs other than the maternal placenta at the time of sacrifice and
necropsy (Sanchez et al., 2006).
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Although serology is an important method of screening for the presence of C.
burnetii within a herd, seroconversion in goats has been evaluated in few studies. An
experimental study and a case-control study in the context of an outbreak of Q fever
have evaluated the relationship between abortion and the detection of anti-C. burnetii
antibodies in goats (Arricau-Bouvery et al., 2003; Rousset et al., 2009). In the
experimental study pregnant does were infected by subcutaneous injection with a strain
of C. burnetii known to be associated with abortion in goats (CbC1). The administered
doses ranged from 104 to 108 organisms (Arricau-Bouvery et al., 2003). None of the does
tested positive by enzyme-linked immunosorbent assay (ELISA) until day 42 after
infection and only 67% were seropositive at the time of abortion. By 80 days after
infection, 91% of the does had seroconverted. Does were sacrificed at 6 weeks postabortion so the duration of the immune response was not determined (Arricau-Bouvery
et al., 2003). Fifty does that experienced abortion and 70 does with normal parturition
were recruited from 8 goat dairies where at least 5 does in the herd had aborted due to
Q fever (Rousset et al., 2009). The recruitment goal for each dairy was 15 does: Five that
had aborted, 5 at full term gestation and due to freshen and 5 that were in the last
month of gestation. However, 10 of the control does aborted and were included as
cases. These does had all been infected by a natural route and the strain of C. burnetii
was not reported. Paired serum samples were collected from the does at 15 and 30 days
after either the peak of abortion at the farm, the last month of gestation or parturition.
Eighty-nine of the does tested positive for exposure to C. burnetii by ELISA (Rousset et
al., 2009). The number of does that seroconverted between day 15 and day 30 was not
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reported and follow-up beyond 30 days was not performed, so duration of the immune
response could not be determined.
In people, the acute form of Q fever was first described in slaughterhouse
workers whose positions included interaction with cattle, sheep or their products
including hides (Derrick, 1937). Q fever is still considered to be an occupational disease
among those who work with livestock (Behymer & Reimann, 1989; Whitney et al., 2009).
Based on the comparison of the number of seropositive individuals with symptomatic
individuals, asymptomatic Q fever is believed to be common in the general population
(Norlander, 2000). The Centers for Disease Control and Prevention estimates that 3% of
the general population of the United States is serologically positive for C. burnetii
exposure (CDC, 2013). The symptoms of acute Q fever are influenza-like, including a
fever ranging from 102.0 to 104.0oF associated with headache. These symptoms last
from 7 to 24 days. The clinical similarity to influenza complicates diagnosis and without
a high index of suspicion Q fever can easily be misdiagnosed (Derrick, 1937; Norlander,
2000; Arricau-Bouvery & Rodolakis, 2005). Complications of acute Q fever can include
hepatitis, either asymptomatic or granulomatous with hepatomegaly, pneumonia and
encephalitis (Norlander, 2000; Arricau-Bouvery & Rodolakis, 2005).
Chronic Q fever may develop in people as a sequelae to acute infection.
Endocarditis and a form of chronic fatigue syndrome are the most common
manifestations of chronic Q fever (Harris et al., 2000; Norlander, 2000; Arricau-Bouvery
& Rodolakis, 2005; Oyston & Davies, 2011). Q fever endocarditis is most likely to
develop in those with pre-existing cardiac abnormalities or immunosuppressive
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conditions (Arricau-Bouvery & Rodolakis, 2005). Post-Q fever fatigue syndrome occurs in
approximately 15% of people diagnosed with acute infection and can linger for up to a
decade after the initial infection with C. burnetii (Harris et al., 2000, Oyston & Davies,
2011). Chronic Q fever results in higher mortality rates than the acute form (Norlander,
2000).
Abortion related to placentitis and other reproductive effects of C. burnetii
infection also occur in women. The active C. burnetii infection does not have to occur
concurrently with pregnancy for reproductive effects such as premature birth, low birth
weight, neonatal mortality and repeated miscarriages to occur (Norlander, 2000,
Arricau-Bouvery & Rodolakis, 2005). In a series of 53 cases of pregnant women
diagnosed with Q fever during pregnancy between 1991 and 2005, only 18.9% of
women infected with C. burnetii had a normal pregnancy outcome. Pregnancy
complications, in descending order of frequency, were: Premature delivery, stillbirth,
intrauterine growth restriction, spontaneous abortion and oligoamnios (Carcopino et al.,
2009). In addition, pregnant women have a higher risk of developing chronic Q fever,
particularly when infection occurs early in pregnancy (Carcopino et al., 2009).
Whether in animals or people, much of the research on the epidemiology of C.
burnetii has been performed in the context of outbreaks of Q fever (Fishbein & Raoult,
1992; Tissot-Dupont et al, 2004; Rousset et al, 2009; Schimmer et al, 2010; Reusken et al,
2011; Rijks et al, 2011; Roest et al, 2011; Hogerwerf et al, 2012; Kersh et al 2013;
Mahamat et al, 2013). Within the past 10 years, 2 outbreaks of note have involved goats
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as the source of human infection. Although different in scale, both of these outbreaks
have contributed to the understanding of the epidemiology of C. burnetii.
In May of 2007, an outbreak of Q fever associated with disease in dairy goat and
sheep farms was documented in the area surrounding a village in the southeastern
region of the Netherlands (van der Hoek et al., 2010). This developed into one of the
largest documented Q fever outbreaks in history with greater than 3000 human cases
reported between 2008 and 2009. In comparison, an average of 17 cases annually was
reported in the Netherlands between 1978 and 2006 (Schimmer et al., 2009; van der
Hoek et al., 2010). Living within 2 kilometers (1.25 miles) of a dairy goat farm with
significant abortion issues was a risk factor for human cases of Q fever (Schimmer et al.,
2010). An emergent strain of C. burnetii was identified by MLVA in the investigation of
this outbreak (Roest et al., 2011) and has since been recognized in Belgium as well
(Boarbi et al., 2014).
In 2011, an outbreak of Q fever in does on a farm in Washington State was
reported. Goats from this farm had been purchased and transported to 21 farms in
Washington, Montana and Oregon prior to the identification of C. burnetii on the
original farm. Of 108 people tested by serology for exposure to C. burnetii, 20 were
linked to at least one of the 17 farms of interest that participated in the broader
investigation (Bjork & Anderson, 2011). Genotyping identified ST8 in 3 environmental
samples and 3 animal isolates associated with this outbreak (Kersh et al., 2013).
Research focusing on the farms involved in this outbreak also determined that human
beings can act as fomites for C. burnetii, transferring the organism from barns into their
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houses although the greatest concentrations of C. burnetii DNA were within 50m of the
areas where parturition or abortion occurred (Kersh et al., 2013).
Outbreaks of Q fever have not been reported in Indiana. However, individual
cases have been reported both to the Indiana State Department of Health (ISDH) and to
the Indiana State Board of Animal Health (ISBOAH). The highest number of annual
human cases, 4, was reported to the ISDH in 2005 (Beall et al., 2007). Reporting of
suspected animal cases to the ISBOAH has also been infrequent with 2 positive cases
documented in sheep in 2008, 1 positive case in a bovine in 2011, 2 positive bovine
cases in 2013 and 5 positive cases in 2015 (1 canine and 4 caprine) (personal
communication, IABOAH). The lack of reported cases of Q fever does not negate the
importance of active research into C. burnetii in Indiana. Indeed, research into the
prevalence of C. burnetii in reservoir species in Indiana can help to either support the
appropriateness of passive surveillance efforts or indicate that active surveillance may
be necessary.
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CHAPTER 3. PREVALENCE OF COXIELLA BURNETII, AGREEMENT BETWEEN
DIAGNOSTIC METHODS AND RELATIONSHIPS WITH BREED PURPOSE IN INDIANA
GOATS

3.1

Introduction

Coxiella burnetii is the causative agent of Q fever, a zoonotic disease with effects
ranging from the absence of clinical signs to acute influenza-like symptoms to vegetative
endocarditis in people (Raoult et al., 2005). First described among abattoir workers in
Australia in 1935 (Derrick, 1937), human Q fever outbreaks continue to occur globally
(Brouqui et al., 2004; Roest et al., 2011; Bjork et al., 2014; Eldin et al., 2014). Although it
has been a reportable disease in the United States since 1999 (McQuiston et al., 2006),
the clinical similarities of the acute form of Q fever to influenza likely lead to
underdiagnosis and thus to underreporting.
Human exposure to C. burnetii can occur by several routes. Direct handling of
placenta and other reproductive materials results in exposure to large numbers of C.
burnetii (Arricau-Bouvery & Rodolakis, 2005). Wind transmission has been associated
with human Q fever outbreaks (Tissot-Dupont et al., 1999; Tissot-Dupont et al., 2004;
Schimmer et al., 2010). Both of these routes of transmission relate to inhalation of
aerosolized C. burnetii. Outbreaks of Q fever have also been associated with the
consumption of unpasteurized dairy products (Fishbein & Raoult, 1992; Signs et al.,
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2012). Q fever is also considered to be a tick borne disease, but few cases of
transmission of C. burnetii by ticks to people have been reported (Eklund et al., 1947). C.
burnetii is presumed to be endemic in domestic ruminants (Norlander, 2000) and
ubiquitous in the environment (Kersh et al.; 2010, Kersh et al., 2013), thus knowledge of
the prevalence of C. burnetii in reservoir species can help public health agencies prepare
for potential Q fever outbreaks.
Small ruminants are commonly associated with human C. burnetii infection and
recent outbreaks in the Netherlands and the United States have been associated with
goats (Roest et al., 2011; Bjork et al., 2014). In goats, late term abortion is the most
common clinical manifestation, but infection with C. burnetii can have varied
presentations, including the absence of symptoms (Arricau-Bouvery & Rodolakis, 2005).
C. burnetii can be shed through the products of parturition, urine, feces and milk. The
greatest number of bacteria are shed in the placenta (Roest et al., 2012), but other
routes of shedding vary in importance by species (Rodolakis et al., 2007). Based on
experimental studies, the primary route of C. burnetii shedding in goats after parturition
or abortion is through milk although shedding in vaginal mucus and feces does occur
(Rodolakis et al., 2007; Roest et al., 2012).
Given its ubiquity, qualifying a herd or location as C. burnetii free is difficult to
impossible. However, a herd with no evidence of infection that has incorporated
preventive measures into its management strategies may be considered low risk
(NASPHV & NASAHO, 2013). Methods to determine low risk herd status have been
defined, including serologic testing of the full herd, monitoring of bulk tank samples for
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C. burnetii DNA by polymerase chain reaction (PCR) and testing of placentas in all
aborted and select normal pregnancies by PCR (NASPHV & NASAHO, 2013). Despite
recommendations for good biosecurity measures at the herd level and requirements for
testing for exposure to C. burnetii prior to international shipment, there are limited
recommendations for evaluating individual animals for infection with C. burnetii before
or at the time of introduction to a herd or flock. Serologic testing of animals can indicate
exposure to C. burnetii if a single sample is positive or active infection if seroconversion
occurs between paired samples. Checking individual samples for the presence of
organismal DNA indicates active infection if samples are positive, but shedding of C.
burnetii can be intermittent (Arricau-Bouvery et al., 2003). Evaluation of the agreement
between diagnostic methods in apparently healthy animals can provide a foundation for
recommendations as to which test or combination of tests is most likely to detect an
individual infected with C. burnetii prior to the introduction of new animals to a low risk
herd or flock.
The first objective of this study was to estimate the prevalence of anti-C. burnetii
antibodies and shedding of C. burnetii DNA among the general population of goats in
Indiana at both the individual and herd levels. The second objective of this study was to
evaluate agreement between serologic and molecular diagnostic methods. A third
objective was to determine if a relationship between breed purpose and infection with
C. burnetii could be identified.
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3.2

Materials and methods

3.2.1 Inclusion criteria, and recruitment
The population of interest for this study was defined as goat does over 1 year of
age and not pregnant at the time of sampling. Does were chosen as the focus of this
study because the greatest number of C. burnetii organisms are shed in placenta and
reproductive discharges at the time of abortion or normal parturition (Roest et al., 2012)
and milk is the primary route of shedding in goats (Rodolakis et al., 2007). In order to
include asymptomatic carriers of C. burnetii, there were no restrictions placed upon
health status or reproductive history although information on reproductive history was
collected. Sample size calculations to determine a target number of herds to recruit
were based on an estimated seropositivity and shedding frequency of 50%, 95%
confidence and a precision of +/-10%. In order to determine the number of does to test
per herd to detect C. burnetii infection at the herd level, a within-herd seroprevalence of
40% and shedding frequency of 50% were assumed with a 95% confidence level defined.
Based upon these definitions, sampling up to 10 does per herd would allow for
detection of C. burnetii within the herd with 95% confidence in herds with up to 100
does.
Goat herds were identified through breed organization directories, internet
searches and personal communication at shows between May of 2012 and August of
2014. Recruitment was through e-mail, telephone conversations and personal
conversations, resulting in a convenience sample. The e-mail recruitment document can
be found in Appendix A. Sampling also occurred between May of 2012 and August of
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2014 at the show or at a farm visit based upon producer preference. In herds with more
than 10 does that met the inclusion criteria, the producer selected those to be sampled.
In herds with fewer than 10 does meeting the inclusion criteria, all were sampled.
3.2.2 Sample collection and storage
Blood and milk samples were collected at a single visit for each doe, as approved
by the Purdue University Animal Care and Use Committee (PACUC protocol
1205000641). Blood samples were collected by jugular venipuncture into serum
separator tubes by the investigators. Milk samples were collected by the owner or the
investigators and normal hygienic procedures for that herd were followed. Sterile
cotton-tipped plastic swabs were used by an investigator to collect samples of vaginal
mucus. In order to ensure that the collected fecal samples represented a single doe,
samples were collected from the rectum by an investigator unless the doe defecated at
any point during sample collection, in which case the immediately voided sample was
collected.
All samples were transported in coolers with ice or ice packs. Upon return to
Purdue University, blood samples were centrifuged at 4,000 rpm for 10 minutes in order
to separate the serum. After centrifugation, 1 to 2ml aliquots of serum were removed
and placed in cryotubes for storage at -20oC prior to testing. Samples were stored at 20oC until DNA extraction was performed unless extraction was performed within 24
hours of sample collection. In this case, samples were kept refrigerated until extraction
was performed and stored at -20oC after extraction.
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3.2.3 Laboratory analysis
Serum samples were tested for anti-C. burnetii antibodies using the Idexx Chekit
Q-fever antibody test (trademark IDEXX Laboratories, Hoofddorp, the Netherlands)
following the manufacturer’s protocol. This enzyme-linked immunosorbent assay (ELISA)
detects both phase I and phase II antibodies and is based upon an antigen derived from
the Nine Mile strain of C. burnetii. In a study performed at the National Veterinary
Service Laboratory (NVSL), the sensitivity of this test was estimated to be 97% and
specificity was estimated to be 100% (Emery et al., 2014), which is a slightly lower
sensitivity than documented by the manufacturer. Positive and negative controls
provided with the kit and serum samples were diluted 1:400 in wash buffer and 100l
aliquots of this dilution were added to the wells of a microtiter plate coated with
inactivated C. burnetii antigen and incubated at 37oC for 60 minutes. Following
incubation, the wells were washed in triplicate with 300l of wash buffer, 100l of antiruminant-IgG-PO conjugate labeled with horseradish peroxidase conjugate was added
to each well and a second incubation at 37oC for 60 minutes was performed. Following
the second incubation, the wells were again washed in triplicate, 100l of TMB
substrate was added to each well and 15 minute incubation was performed at room
temperature. Finally, 100l of STOP solution was added to each well and the optical
densities (OD) were read. Based upon the manufacturer’s recommendations, a positive
sample was defined as one that demonstrated an optical density greater than or equal
to 40% of that of the positive controls run with the assay. A negative sample was
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defined as one that demonstrated an OD less than 30% of that of the positive control
after correction by subtraction of the OD of the negative control. Samples with OD
between 30 and 40% of the positive control after correction by subtraction of the
negative control were defined as indeterminate and retested.
A Qiagen DNeasy Blood and Tissue Kit (trademark Qiagen, Valencia, California)
was used for the extraction of DNA from milk samples. After homogenization by vortex,
200l of milk was combined with 180l Buffer ATL and 20l proteinase K, mixed by
vortex and incubated for at least 3 hours at 55oC. After this incubation, 400l of Buffer
AL was added to each sample and a 70oC incubation was performed for 10 minutes after
mixing by vortex. Ethanol (400l) was added to the mix and the lysate was filtered
through columns using Buffers AW1 and AW2. Buffer AE was added to the columns for
a final elution volume of 200l.
A Qiagen DNeasy Blood and Tissue Kit protocol for DNA extraction from buccal
swabs was utilized for DNA extraction from the vaginal samples. Swabs were suspended
in 400l sterile PBS. After suspension, 20l Proteinase K and 400l Buffer AL were then
added to each sample. Swabs and reagents were mixed by vortex, incubated at 56 oC for
10 minutes and briefly centrifuged prior to adding 400l ethanol to the lysate. The
lysate was filtered through columns and washed with buffers AW1 and AW2. Buffer AE
(150l) was added to the columns for the final elution.
A QIAamp DNA Stool Mini Kit (trademark Qiagen, Valencia, California) was utilized
for DNA extraction from fecal samples. Individual sample aliquots of 200mg of feces
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were used for each extraction. One ml of Inhibitex Buffer was added to each sample,
vortexed to mix and incubated at 95oC for 5 minutes prior to centrifugation. After
centrifugation, 200l of supernatant was added to 15l Proteinase K and 200l of Buffer
AL was added. Samples were mixed by vortex and incubated at 70oC for 10 minutes.
After incubation, 200l ethanol was added to the lysate, mixed by vortex and 600l of
the lysate was filtered through columns and washed with buffers AW1 and AW2. Buffer
ATE (200l) was used for the final elution. All DNA samples were stored at -20oC prior to
PCR testing.
The real time PCR targeted an 86 base pair section of the IS1111 transposon as
defined by Panning (Panning et al., 2008). The forward primer CburF, 5’-GAT AGC CCG
ATA AGC ATC AAC – 3’ (Life Technologies, Carlsbad, CA, USA), reverse primer CburR, 5’ –
GCA TTC GTA TAT CCG GCA TC – 3’ (Life Technologies, Carlsbad, CA, USA) and probe
Cbur 5’ – FAM – TCA TCA AGG CAC CAA T – MGBNFQ – 3’ (Life Technologies, Carlsbad,
CA, USA) were used (Panning et al., 2008). The reaction mixture consisted of 2.5l of
magnesium free 10x reaction buffer (Invitrogen, Life Technologies, Carlsbad, CA), 2.0l
of 50mM magnesium chloride (Invitrogen, Life Technologies, Carlsbad, CA), 0.5l of
10mM dNTPs (Applied Biosystems, Warrington, UK), 2.0l of CburF, 2.0l of CburR,
0.5l of Cbur probe, 0.1l Platinum Taq polymerase (trademark Invitrogen, Life
Technologies, Carlsbad, CA) and 10.15l of nuclease free water plus 5l of DNA sample.
A Stratagene Mx3000P qPCR system (trademark Agilent Technologies, Santa Clara, CA)
was utilized to perform an amplification protocol of 95oC for 10 minutes for strand
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separation, followed by 45 repeated cycles of 95oC for 15 seconds for strand separation
and 60oC for 30 seconds for annealing and amplification (Panning et al., 2008).
Amplification data was collected in MxPro (trademark Agilent Technologies, Santa Clara,
CA). Based upon a standard curve generated through use of a plasmid containing the 86
base pair target sequence the analytic sensitivity of this PCR was determined to be 100
copies of the IS1111 transposon (Bauer et al., 2015), having a CT of 36.5. Samples
demonstrating cycle threshold (CT) values on the initial PCR were run in duplicate and
those with average CTs less than or equal to 36.5 were considered positive for purposes
of analysis. A negative control of nuclease free water and positive control of C. burnetii
DNA extracted from cattle milk from a previous study (Bauer et al., 2015) were run with
each PCR. Due to variation of copy numbers of the IS1111 transposon by strain of C.
burnetii (Klee et al., 2006), the number of individual bacteria detectable by this assay
was not determined.
3.2.4 Statistical analysis
Individual and herd level prevalence estimates and 95% confidence intervals (CI)
were calculated in OpenEpi (Dean et al., 2014). The 95% confidence intervals were
calculated using the Wilson score method. The sensitivity and specificity values reported
in the NVSL study (97% and 100% respectively) (Emery et al., 2014) were used to
calculate adjusted seroprevalence within the sample utilizing the formula: p(D+) =
(Apparent prevalence + Specificity – 1)/(Sensitivity + Specificity – 1) (Dohoo et al., 2009).
Individual level calculations for apparent prevalence were based upon the number of
does positive for C. burnetii by the given diagnostic method divided by the total number

47
of does tested by that method. Herd level calculations were based upon the number of
positive herds by the given diagnostic method divided by the total number of herds
tested by that method. Prevalence estimates and 95% confidence intervals were
calculated at both herd and individual levels for both seropositivity and shedding of C.
burnetii DNA in all sample types tested by PCR.
In order to determine whether the serology and DNA shedding results were in
agreement, Cohen’s kappa (Cohen, 1960) was calculated in IBM SPSS Statistics for
Windows version 22.0 (Released 2013 IBM Corp. Armonk, NY) for both individuals and
herds. Point estimates for kappa as well as 95% confidence intervals are presented.
Percent concordance between test results was also calculated.
A Chi-square test of association was performed in SPSS to evaluate the association
between breed type and the binary laboratory test results for individual anti-C. burnetii
antibodies and C. burnetii DNA shedding. The breed type was defined as dairy, meat,
fiber or unknown, but due to small numbers of does in the fiber and unknown groups,
only individuals classified as dairy or meat breeds were used in the analysis. Dairy breed
was used as the comparison group for the calculation of odds ratios. A test of
association was also run at the herd level to evaluate if there was an association
between herds with meat breeds of goat present and seropositivity for C. burnetii or
shedding of C. burnetii DNA.
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3.3

Results

3.3.1 Sample
A total of 649 does representing 94 farms from 49 counties in Indiana were
included in the study. Does ranged in age from 1 to 14 years with a median of 2 years.
The majority of does sampled (n=414, 63.8%) were from dairy breeds, followed by meat
breeds (n=223, 34.4%). Ten fiber breed does were included in the study. An unidentified
breed group consisted of 2 individuals.
Farms included in this study were not necessarily limited to one breed of goat or
even one breed type. Of farms limited to a single breed type, 48 had dairy breed goats
only and 21 had meat breed goats only. A single farm had only fiber breed goats.
Twenty-four farms had both dairy and meat breed goats present in the herd.
3.3.2 Prevalence estimates
Serum samples were collected from a total of 608 does representing 89 farms.
Twenty-three of the samples tested by ELISA were positive for anti-C. burnetii antibodies.
These samples came from 10 different farms. The estimated herd and individual
seroprevalences for anti-C. burnetii antibodies are displayed in Table 3.1 and were 11.2%
(95% CI: 6.2-19.5%) and 3.8% (95% CI: 2.5-5.6%), respectively. Utilizing the sensitivity
and specificity values calculated at the NVSL (Emery et al., 2014) to calculate real
prevalence did not result in any changes in the seroprevalence estimates.
DNA samples from at least one of the three sources (milk, vaginal swabs or feces)
were tested for the IS1111 transposon by real time PCR for 649 does, representing all 94
of the farms. A total of 49 does were positive for C. burnetii DNA by at least 1 route of
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shedding. The positive samples came from 19 different farms. The estimated individual
and herd level prevalences for shedding C. burnetii DNA are displayed in Table 3.1 and
were 7.5% (95% CI: 5.7-9.8%) and 20.2% (95% CI: 13.3-29.4%) respectively.
Table 3.1 also includes prevalence estimates based upon the source of the DNA
sample. Milk samples were collected from 387 does representing 83 farms. Nine of the
individual milk samples from 6 farms were positive for C. burnetii DNA. The estimated
prevalence of shedding C. burnetii in milk by individual does was 2.3% (95% CI: 1.2-4.4%).
The estimated herd level prevalence of C. burnetii infection based on milk samples was
7.2% (95% CI: 3.3-14.9%).
Swab samples of vaginal mucus were collected from 632 does representing 92
farms. Forty of these samples from 14 farms were positive for C. burnetii DNA. The
estimated prevalence of C. burnetii shedding by individual does in Indiana in
reproductive discharges was 6.3% (95% CI: 4.7-8.5%). The estimated herd level
prevalence for C. burnetii infection based on sampling reproductive discharges was 15.2%
(95% CI: 9.3-23.9%).
Fecal samples were collected from 574 individual does representing 92 farms.
Only a single fecal sample tested positive for C. burnetii by PCR. The estimated
prevalence of C. burnetii based on testing fecal samples was 0.2% (95%CI: 0.03-1.0%). At
the herd level, the estimated prevalence of infection with C. burnetii based upon fecal
samples was 1.1% (95% CI: 0.2-5.9%).
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3.3.3 Agreement between diagnostic samples
Table 3.2 details the relationship between serology and overall PCR results. Both
serum and DNA samples were tested in 608 does from 89 farms. Six does from 3 farms
were positive for C. burnetii by both ELISA and PCR. Five-hundred-forty-three does from
63 farms were negative for C. burnetii by both ELISA and PCR. In general, the agreement
between ELISA and PCR was poor both at the individual (kappa=0.12, 95%CI: 0.005-0.24)
and farm (kappa=0.07, 95%CI: -0.14, 0.28) levels, but percent concordance, which takes
into account agreement between negative test results, was high at both levels (90.3%
and 70.8% respectively).
When the specific types of samples used as DNA sources were evaluated for
agreement with serologic results (Table 3.3 and Table 3.4), agreement was consistently
poor. The agreement between ELISA and PCR detection of C. burnetii DNA in milk
samples was 0.04 (95% CI: -0.10-0.18) for the individual does tested and 0.17 (95%CI: 0.12 – 0.47) at the herd level. Percent concordance was 93.0% for individuals and 85.0%
at the herd level. The measure of agreement between ELISA and PCR of samples
collected by vaginal swab was 0.16 (95% CI: 0.02-0.29) and percent concordance was
91.9% for the individual does tested. At the herd level, kappa was 0.04 (95%CI: -0.180.26) and percent concordance was 77.5%. The measure of agreement between ELISA
and PCR of fecal samples was -0.003 (95% CI: -0.009, 0.003) and percent concordance
was 96.3% for individual does. At the herd level, the kappa coefficient was -0.02 (95% CI:
-0.06-0.02) and percent concordance was 87.5%.
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3.3.4 Comparing meat and dairy breeds
The majority of the 598 does serosampled and included in breed analysis were
from dairy breeds (64.2%, Table 3.5). Meat breeds provided 35.8% of the samples.
Twenty-two of the 89 farms providing serum samples had both meat and dairy breeds
present in their herds (24.7%). Twenty-one farms (23.6%) had only meat breeds in their
herds and 45 farms (50.6%) had only dairy breeds. Seventeen dairy does were
seropositive for anti-C. burnetii antibodies, a seroprevalence within the dairy breeds of
4.4% (95% CI: 2.8-6.9%). Six meat does were positive for anti-C. burnetii antibodies, a
seroprevalence within the meat breeds of 2.8% (95% CI: 1.3-6.0%). No statistically
significant difference in seroprevalence between dairy and meat breeds was detected
by the cross-tab analysis, although there was a decreased odds of detecting anti-C.
burnetii antibodies in meat breed does when compared to dairy breed does (OR=0.62,
95% CI: 0.24–1.60, p=0.32). There was no practical or statistically significant difference
in the odds of a farm testing positive for anti-C. burnetii antibodies based upon the
presence of meat breed goats in the herd (OR=1.08, 95% CI: 0.29–4.02, p=0.91).
The majority of the 637 does providing DNA samples and included in breed
analysis were from dairy breeds (65.0%, Table 3.5). Meat breeds provided 35.0% of the
samples. Twenty-three of the 93 farms providing serum samples had both meat and
dairy breeds present in their herds (24.7%). Twenty-one farms (22.6%) had only meat
breeds in their herds and 49 farms (52.7%) had only dairy breeds. Forty-one of the dairy
breed does tested positive for C. burnetii DNA. Prevalence of shedding C. burnetii within
the dairy does in this study was 9.9% (7.4-13.1%). Eight of the meat breed does tested
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positive for C. burnetii DNA. Prevalence within the meat breed does in this study was 3.6%
(1.8-6.9%). Overall, a meat breed doe had a reduction in the odds of testing positive for
C. burnetii in a DNA sample of 3.3 folds as compared to a dairy breed doe (OR=0.34, 95%
CI: 0.16–0.73, p=0.006).
Tables 3.6 and 3.7 detail the relationships between meat and dairy breed does
and testing positive for C. burnetii DNA in milk and vaginal swab samples at the
individual and herd levels. It is of note that meat breed does were 8.7 times more likely
to test positive for C. burnetii DNA in a milk sample than dairy breed does (OR=8.69, 95%
CI: 1.81-55.24, p=0.0049) , but had an 11.1 fold reduction in the odds of testing positive
in a vaginal swab sample (OR=0.09, 95% CI: 0.02-0.37, p<0.001). There was no practical
or statistically significant difference in the odds of a farm testing positive for C. burnetii
DNA based upon the presence of meat breed goats in the herd (OR=0.79, 95% CI: 0.28–
2.18, p=0.65). The presence of meat breeds in the herd had no statistically significant
effect on the detection of C. burnetii DNA in either milk or vaginal mucus samples.
3.4

Discussion

Estimations of C. burnetii prevalence vary depending the sample source and type
of testing. The estimated seroprevalence of 3.8% in Indiana determined in this study is
somewhat lower than the seroprevalence findings of 8.0% reported in Washington State
(Sondgeroth et al., 2013) and somewhat higher than 1.2% reported in Boer goats in
Missouri (Baker & Pithua, 2014). The overall 7.5% prevalence of shedding of C. burnetii
DNA in this study is lower than that determined in other studies (Arricau-Bouvery et al.,
2003). In a study comparing shedding routes in does from farms under outbreak
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conditions, milk samples tested positive for C. burnetii DNA in 38% of does that had
experienced abortion and 31% of does with normal parturition (Rousset et al., 2009).
Lower prevalence estimates in this study may reflect either the choice to sample
outside of an ongoing outbreak, or the timing of sampling in relation to parturition.
After experimental infection by subcutaneous injection, milk shedding was found to
continue for 52 days after abortion (Arricau-Bouvery et al., 2003). Sampling dates in this
study ranged from less than 1 month to 36 months after the most recent freshening and
the period for shedding of C. burnetii DNA may have been missed in those individuals
that had freshened several months prior to sampling.
Based on the use of Cohen’s kappa, seropositivity for C. burnetii has poor
agreement with shedding of the bacteria as determined by identification of the IS1111
transposon at both the individual and herd levels. Although specifically developed for
nominal scales (Cohen, 1960), a kappa coefficient was chosen to evaluate agreement
between test results in this study because all results were defined as binary (positive or
negative for evidence of C. burnetii) and thus no linear relationship could be assumed.
A weakness of the kappa coefficient is its dependence upon prevalence (Byrt et al.,
1993). Percent concordances between ELISA and overall PCR results in this study were
90.3% at the individual level and 70.8% at the herd level indicating that the majority of
the paired samples were in agreement as negative results. The discrepancy between
agreement and concordance is in part due to the low prevalence of C. burnetii in the
does and herds in this study as the majority of the concordant pairs at both levels are
negative results (Table 3.2). The low seroprevalence (3.8% at the individual level and
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11.2% at the herd level) and DNA shedding prevalence values (7.5% at the individual
level and 20.2% at the herd level) in this study contribute to a low kappa value.
Choosing to focus on individuals with a history of recent reproductive disease
may have helped to address the effect of low prevalence on the kappa statistics.
Reproductive history did not play a defined role in sample selection in this study,
although since this was a convenience sample selection bias is certainly a concern in
interpretation of the results. Animals living on farms where reproductive events have
occurred would be more likely to have been exposed to, and exhibit titers against, C.
burnetii as compared to animals on farms where reproductive events have not occurred.
However, it is likely that the kappa statistic would indicate a poor level of agreement
even if the prevalence estimates in this study were higher. The lack of agreement
between molecular and serologic tests for C. burnetii previously documented in the
contexts of outbreaks of Q fever and in experimental research, supports this conclusion.
Eighteen of 72 goats identified as shedding C. burnetii DNA during a Q fever outbreak
were negative for anti-C. burnetii antibodies by the same ELISA used in this study
(Rousset et al., 2009). After experimental infection, fewer than half of the infected does
(6/19) had detectable anti-C. burnetii antibodies at the time of abortion, regardless of
the dose of C. burnetii administered (Arricau-Bouvery et al., 2003).
No statistically significant difference was noted between seroprevalence of anti-C.
burnetii antibodies in meat breeds of goat as compared to dairy breeds. Although an
odds ratio of 0.6 was calculated when comparing meat breeds to dairy breeds by exact
logistic regression, wide confidence intervals indicate that the sample size is too small to
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draw a clear conclusion about this relationship. There was a statistically significant
difference noted in the prevalence of C. burnetii DNA in milk from meat breeds of goats
as compared to dairy breeds and meat breed does were 8.7 times more likely to be
shedding C. burnetii in milk samples. This finding may be related to clustering of animals
as 4 of these does were from the same farm.
A unique feature of this study sample is that farms did not necessarily have a
single breed, or even only dairy or meat breeds, present in the herd. This created an
opportunity to evaluate the effect of mixed purpose herds on the odds of detecting
infection with C. burnetii. In this study, farms that included meat breeds of goat in their
herds had no statistically significant increase in the odds of being positive for either antiC. burnetii antibodies or shedding of C. burnetii DNA than those farms that did not have
goats from meat breeds in the herd.
Breed purpose may be a surrogate for either management factors that vary
between meat and dairy operations or for physiologic or immune differences between
meat and dairy breeds. At least one seroprevalence study has been performed focusing
on a single breed of goat, the Boer goat (Baker & Pithua, 2014). However, breed specific
studies evaluating shedding of C. burnetii DNA have not been performed. Studies
focusing on breed classifications or specific breeds, particularly if does that had
experienced reproductive events were the group of interest, would help to elucidate
whether the predisposition to C. burnetii shedding in milk identified here is a
generalizable finding, and if so can be associated with husbandry rather than the breeds
themselves.
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In conclusion, seroprevalence of C. burnetii in goats in Indiana and the prevalence
of does shedding C. burnetii DNA are both low in Indiana. However, 20% of the herds
included in this study had at least 1 doe shedding C. burnetii DNA at the time of
sampling. This represents a potential for exposure to people interacting with these
herds. In this study, there was a greater proportion of C. burnetii DNA shed in milk
samples from meat breed does as compared to dairy breeds, which may reflect the
clustering effect of farm, differences in husbandry between goats used for different
purposes or intrinsic factors related to breed. Finally, while not precluding serology as a
screening method for exposure to C. burnetii, lack of agreement between results of
ELISA and PCR at both the individual and herd levels indicates that a single serum
sample is not an appropriate choice for identification of active C. burnetii infection in
individual does prior to introduction to a low risk herd. Indeed, the presence of the lack
of agreement indicates that exclusion of individual animals from a herd based solely on
seropositivity will not prevent entry of C. burnetii into that herd.
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Table 3-1. Estimated individual and herd level prevalence by sample type
Number

Number

Number
Estimated

Number

of

Estimated

95%

of herds

of

of does

positive

Prevalence

CI

tested

positive

Sample

herd

95% CI

prevalence
does

herds
2.5 –

Serum

608

23

89

3.8%

10

11.2%

19

20.2%

6.2 – 19.5%

5.6%
5.7 –
DNA

649

49

94

7.5%

13.3 –

9.8%
1.2Milk

387

9

29.4%
83

2.3%

6

7.2%

3.3-14.9%

14

15.2%

9.3-22.9%

1

1.1%

0.2-5.9%

4.4%
4.6Vaginal

632

40

92

6.3%
8.5%
0.03-

Feces

574

1

0.2%
1.0%

92
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Table 3-2. Concordant and discordant results between ELISA and PCR samples at the
individual and herd levels.
Test

Individual

ELISA
Herd

PCR
Positive

Negative

Total

Positive

6

17

23

Negative

42

543

585

Total

48

560

608

Positive

3

7

10

Negative

16

63

79

Total

19

70

89

62
Table 3-3. Concordant and discordant results between ELISA and PCR at the individual
level when compared by the source of DNA
Test

PCR
Milk

ELISA

Swab

Feces

Positive

Negative

Total

Positive

Negative

Total

Positive

Negative

Total

Positive

1

17

18

6

16

22

0

20

20

Negative

8

330

338

33

549

582

1

528

529

Total

9

347

356

39

565

604

1

548

549
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Table 3-4. Concordant and discordant results between ELISA and PCR at the herd level
when compared by the source of DNA
Test

PCR
Milk

ELISA

Swab

Feces

Positive

Negative

Total

Positive

Negative

Total

Positive

Negative

Total

Positive

2

8

10

2

8

10

0

10

10

Negative

4

66

70

12

67

79

1

77

78

Total

6

74

80

14

75

89

1

87

88
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Table 3-5. ELISA and PCR results for meat breeds as compared to dairy breeds at the
individual and herd level

Individual
Breed type

ELISA

PCR

Positive

Negative

Total

Positive

Negative

Total

Meat

6

208

214

8

215

223

Milk

17

367

384

41

373

414

Total

23

575

598

49

588

637

Meat present

5

38

43

8

36

44

Dairy only

5

40

45

11

38

49

Total

10

78

88

19

74

93

Herd type
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Table 3-6. Comparing the proportions of individual meat and dairy breed does testing
positive for C. burnetii DNA collected from milk and reproductive sources

Breed type

Milk

Reproductive

Positive

Negative

Total

Positive

Negative

Total

Meat

6

70

76

2

218

220

Dairy

3

304

307

38

362

400

Total

9

374

383

40

580

620
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Table 3-7. Comparing the proportions of herds containing meat breed does and dairy
breed does only testing positive for C. burnetii DNA collected from milk and
reproductive sources

Milk

Reproductive

Positive

Negative

Total

Positive

Negative

Total

Meat present

3

33

36

4

40

44

Milk only

3

46

49

10

38

48

Total

6

79

85

14

74

92

Farm type

67

CHAPTER 4.

GEOGRAPHIC DISTRIBUTION OF COXIELLA BURNETII IN INDIANA GOATS

4.1

Introduction

Coxiella burnetii is an obligate intracellular bacterium distantly related to the
Ricketsiales and Legionellaceae (Drancourt & Raoult, 2005). Infection with this zoonotic
agent is often inapparent in both human and animal hosts, but the clinical disease, Q
fever, can be dramatic in its manifestations. In humans the acute form of Q fever results
in influenza-like symptoms that have been reported to last up to 57 days without
treatment (Parker et al., 2006). Pneumonia, hepatitis and pregnancy loss can also occur
as complications of acute Q fever. The chronic form of Q fever most commonly
manifests as endocarditis, but chronic fatigue syndrome and recurrent pregnancy loss
can also occur. Individuals with immunosuppressive conditions or a history of
cardiovascular disease are at a greater risk of developing chronic Q fever (Raoult et al.,
2005).
Q fever was classified as a reportable disease in people in the United States in 1999. The
number of cases reported annually in the United States between 2000 and 2007 ranged
from 17 to 167 and demonstrated an increasing trend (CDC, 2013). This trend may be
due to an increasing incidence of Q fever or it may be that designation as reportable
increased physician awareness of the disease. However, given the clinical similarities
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between acute Q fever and influenza, there is still likely to be underdiagnosis and
underreporting. In Indiana, the number of annually reported cases of Q fever ranged
from 0 to 4 between 2000 and 2007. The peak number of cases, 4, was reported in 2005
(Beall et al., 2002; Beall et al., 2004; Beall et al., 2006a; Beall et al., 2006b; Beall et al.,
2007a; Beall et al., 2007b; Beall et al., 2007c; Staggs et al., 2009).
Domestic ruminants are the main reservoir hosts associated with human Q fever.
In recent years goats have been associated with several outbreaks of Q fever in people.
The largest historically documented outbreak of Q fever occurred in the Netherlands
and was associated with dairy goats (Roest et al., 2011). The first American outbreak
involving multiple states was also associated with goats (Bjork et al., 2014). As with
human infection with C. burnetii, there are often no clinical signs of infection in goats.
The most common clinical sign in this species is late term abortion, which is similar to
several other pathogens including Toxoplasma gondii and Leptospira interrogans (Merck,
2005). Large numbers of C. burnetii are shed into the environment at the time of
abortion and normal parturition. This, along with an infectious dose of C. burnetii of 1 to
10 organisms and an aerosol route of transmission, (Oyston & Davies, 2011) poses a
great risk of infection for people assisting with and cleaning after parturition. Shedding
of C. burnetii also occurs through milk and through fecal material (Rodolakis et al, 2007).
Between 2008 and 2015, 26 animals tested for C. burnetii were reported to the Indiana
State Board of Animal Health (personal communication). Ten of these animals were
confirmed positive for C. burnetii either by complement fixation or polymerase chain
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reaction (PCR) testing. Eight of the animals tested were goats and 4 of these were
confirmed positive for infection with C. burnetii by PCR.
The purpose of this study was to evaluate the geographic distribution of C.
burnetii infection of goats in Indiana. A secondary objective of this study was to identify
and evaluate the geographic distribution of the genetic strains or sequence types (ST) of
C. burnetii present in goats in Indiana. Although Q fever is a rare diagnosis in people in
Indiana, identifying high risk regions of the state can help to plan intervention and
surveillance measures aimed to promote early detection and control of C. burnetii
outbreaks.
4.2

Materials and methods

A convenience sample was collected for this study. Farms with goats were
identified using breed organization directories, internet searches and personal
communications at shows. Recruitment of farms was performed at shows or through email and telephone conversations. Producers that agreed to participate provided
informed consent for sample collection from does over 1 year of age and not pregnant
at the time of sampling as approved by the Purdue University Animal Care and Use
Committee (protocol 1205000641). The producers also provided informed consent to
participate in surveys about their farms, husbandry procedures and histories of the
individual goats sampled. These surveys were approved by the Purdue University
Institutional Review Board and included questions about the zip code and county of the
farm’s location in addition to history of showing and methods of breeding. Farms and
animals were identified by a numeric code rather than name to protect confidentiality.
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Participants were advised that they could choose to decline certain sampling procedures,
refuse to answer certain questions on the surveys and withdraw from participation in
the study at any time.
Geographic regions of Indiana were defined based upon zip codes, public health
preparedness districts (PHPD) and regions (see Figure 4.1 for PHPD and region
boundaries). The number of goat farms and individual goats in each PHPD and region
was calculated upon the National Agricultural Statistics Service’s Census of Agriculture
for 2012 (USDA, 2012). The percentage of goat farms per PHPD and region were
calculated in order to evaluate the representativeness of the sample as compared to the
known distribution of goats in Indiana in 2012. Maps of the geographic regions as well
as the geographic distributions of goats and farms in 2012 and the locations of the goats
and farms sampled at the zip code level were generated using the ArcMap function in
ArcGIS10.3 (Copyright © Esri. All rights reserved).
4.2.1 Diagnostic samples
After sample collection, samples were transported to the laboratory at Purdue
University on ice. Serum was separated by centrifugation at 4,000 rpm for 10 minutes
and 1 to 2 ml aliquots were removed and stored at -20oC. The presence of anti-C.
burnetii antibodies in each sample was identified by use of the commercially available
Chekit-Q fever enzyme-linked immunosorbent assay (ELISA) (trademark IDEXX
Laboratories, Hoofddorp, the Netherlands). This test detects both phase I and phase II
antibody responses to C. burnetii infection. Analyses were performed following the
manufacturer’s instructions. Paired negative and positive controls provided by the
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manufacturer were tested with each group of samples. Positive samples demonstrated
an optical density greater than or equal to 40% of that of the positive controls run with
the assay. A negative sample was defined as one that demonstrated an OD less than 30%
of that of the positive control after correction by subtraction of the OD of the negative
control. Samples with OD between 30 and 40% of the positive control after correction
by subtraction of the negative control were defined as indeterminate and retested.
Samples of milk, vaginal mucus and feces were collected from each individual
doe for DNA extraction and testing for the presence of C. burnetii by real time
polymerase chain reaction (PCR). All samples were transported from the farm or show
to Purdue University on ice and stored at -20oC unless DNA extraction was performed
within 24 hours of sample collection. In the latter circumstance, samples were stored
under refrigeration until extraction could be performed. After homogenization using a
vortex, 200l of milk was utilized as the source for DNA extraction by column with a
Qiagen DNeasy Blood and Tissue Kit (trademark Qiagen, Valencia, California) following a
previously reported protocol (Bauer et al., 2015).
The Qiagen DNeasy Blood and Tissue Kit™ was also utilized for extraction of DNA
from the sterile cotton-tipped swabs used to collect vaginal discharges. The
manufacturer’s protocol for DNA extraction from cheek swabs was followed. Swabs
were suspended in 400l sterile PBS, 20l Proteinase K and 400l Buffer AL were then
added to each sample. Swabs were mixed by vortex, incubated at 56 oC for 10 minutes
and briefly centrifuged prior to adding 400l ethanol to the lysate. The lysate was
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filtered through columns and washed with buffers AW1 and AW2. Buffer AE was added
to the columns for a final elution volume of 150l.
A QIAmp DNA Stool Mini Kit™ (Qiagen, Valencia, California) was utilized to
perform DNA extraction from the fecal samples following the manufacturer’s protocol
with the adjustment of temperature to 95oC for the initial incubation step. In brief, an
initial volume of 200mg of feces was suspended in 1ml of Inhibitex Buffer, mixed by
vortex and incubated at 95oC for 5 minutes prior to centrifugation. After centrifugation,
200l of the resulting supernatant was added to 15l Proteinase K followed by 200l of
Buffer AL. Samples were mixed by vortex and incubated at 70oC for 10 minutes.
Following this final incubation, 200l ethanol was added to the lysate, mixed by vortex
and 600l was filtered through columns and washed with buffers AW1 and AW2. Buffer
ATE was used for the final elution, producing a final volume of 200l.
Real time PCR was utilized to amplify an 86 base pair section of the IS1111
transposon of C. burnetii (Panning et al., 2008; Bauer et al., 2015). Samples
demonstrating an average cycle threshold value of 36.5 or less on repeated
amplifications were defined as positive for the presence of C. burnetii DNA. This cut-off
value was determined based upon evaluation of a standard curve developed for the
target DNA sequence through use of a plasmid created by the pGEM –T vector system
(trademark Promega Corporation, Madison, Wisconsin, USA). For the purposes of the
current study, individual does that tested positive either for anti-C. burnetii antibodies
or for C. burnetii DNA in at least 1 sample were defined as positive individuals.
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4.2.2 Sequence typing
DNA from selected vaginal swab samples was submitted to the Center for
Microbial Genetics and Genomics at Northern Arizona University for genotyping utilizing
single nucleotide polymorphism (SNP) analysis to identify the multispacer sequence
type (MST) (Glazunova et al, 2005). TaqMan assays for SNPs at 2 loci on the IS1111
transposon were performed (Hornstra et al, 2011). The loci tested, 51bp67 and 22bp118,
were chosen to target ST8, the most common C. burnetii ST identified in samples from
goats in the United States (Pearson et al, 2014). The reaction mix for each sample
consisted of 5l 2x TaqMan Universal PCR Master Mix (trademark Life Technologies, CA,
USA), 0.45 l of each primer, 0.1l of each probe and 2.9l of sterile nuclease-free
water to which 1l of DNA was added for a total reaction volume of 10l (Hornstra et al.,
2011). An applied Biosystems 7900HT Fast real-time PCR system was utilized for
reaction conditions of: 50oC for 2 minutes, 95oC for 10 minutes, 45 cycles of 95oC for 15
seconds and 60oC for 1 minute and Sequence Detection System v2.4 software
(trademark Life Technologies, CA, USA) was utilized to recognize and record the SNPs
(Bauer et al., 2015).
4.2.3 Statistical analysis
In order to evaluate how well the study sample represented the true geographic
distribution of goats in Indiana, the percentage of total does sampled from a given PHPD
and region of Indiana were compared with the percentage of total does reported in the
2012 National Census of Agriculture (USDA 2012) for the same PHPD and region of the
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state utilizing a chi-square goodness of fit test in SPSS (SPSS Statistics for Windows,
Version 22.0 Armonk, NY: IBM Corp Released 2013). The expected number of sampled
goats for each region or PHPD were calculated based upon the percent of the total goats
in Indiana present in that PHPD or region. Chi-square tests of association were also
performed to evaluate deviations between the expected prevalence of C. burnetii,
calculated based on the overall estimated prevalence for the state of Indiana, in a given
region or PHPD and the observed prevalence of C. burnetii at the individual and farm
levels. Where statistically significant differences were detected by the chi-square tests
of association, odds ratios comparing each region to a selected comparison region and
each PHPD to a selected PHPD were calculated in SPSS.
4.3

Results

4.3.1 Geographic associations
Based on the information collected in the 2012 Census of Agriculture, there were
38632 goats on 2883 premises in the state of Indiana (USDA, 2012). As illustrated in
Figure 4.2, the number of goats reported per county ranged from 17 in Union County to
2618 in Elkhart County. The median number of goats per county was 351.5. The number
of premises owning goats per county ranged from 5 farms in Union and Marion Counties
to 121 farms in LaGrange County. The median number of farms per county was 27.5.
Samples in this study were collected between May of 2012 and August of 2014 from 649
goats representing 94 farms from 49 counties in Indiana. Each of the 3 regions and 10
PHPDs in Indiana was represented in this sample (Table 4.1). Based on the Chi-square
goodness of fit analysis, there was a statistically significant difference between the
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spatial distribution of the total number of goats in Indiana and the study sample at both
the regional and the PHPD levels (p<0.001 for both levels). The representation of PHPDs
2, 3, and 9 differed by at least 5 percentage points between the sample and the overall
population of goats in Indiana. At the regional level, the percentage of goats sampled
from the Southern region differed from the population percentage by 7 percent.
Table 4.2 details the prevalence estimates for individual does by region and
PHPD. At the state level, 10.2% of the does (n=66) tested positive for C. burnetii by
either serology or PCR. Regionally, the Southern region had the highest prevalence of
does testing positive for infection with C. burnetii (13.5%, n=22). There was no
statistically significant difference detected between regions in the prevalence of
infection with C. burnetii in individual does (p=0.20). At the PHPD level, PHPD 9 had the
greatest prevalence of C. burnetii in the sampled does (20.3%, n=16) while PHPD 7 did
not have any does test positive for C. burnetii. There was a statistically significant
difference detected between PHPDs in the prevalence of C. burnetii infection in
individual does (p=0.042).
Table 4.3 details the farm level prevalence estimates by region and PHPD. At the
state level, 28.7% of the farms (n=27) had at least 1 doe that tested positive for C.
burnetii by either serology or PCR. The Southern region also had the largest proportion
of positive farms (34.8%, n=8). There was no statistically significant difference detected
between regions in the prevalence of infection with C. burnetii at the farm level (p=0.75).
At the farm level, PHPD 9 also had the highest prevalence of C. burnetii in the sampled
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farms (44.4%, n=4). There was no significant difference detected between PHPDs in the
prevalence of C. burnetii at the farm level (p=0.83).
Odds ratios were calculated for C. burnetii infection in individual does at the
PHPD scale. PHPD 1 was chosen as the comparison district and results are shown in
Table 4.4. There was no statistically significant difference in the odds of a doe testing
positive for C. burnetii detected among the PHPDs. However, there was a pronounced
increase in the odds of a doe testing positive for C. burnetii in PHPD 9 as compared to
PHPD 1 (OR=4.09, 95%CI: 0.89-19.20).
4.3.2 Genotyping
Although 162 DNA samples (156 vaginal swab and 6 milk) were submitted for
genotyping, a sequence type was identified for only 3 of the samples. These were
identified as ST8 through the presence of the derived nucleotide C at Cox51bp67. An
additional sample could not be ruled out from being ST8 based upon the amplification
of the derived allele at site 22bp118, but could not be confirmed as ST8. The 4 samples
were from 3 different farms. There was no apparent geographic relationship between
the farms as 1 was located in Steuben County (PHPD 3, Northern region), 1 in Henry
County (PHPD 6, Central region) and 1 in Decatur County (PHPD 9, Southern region). The
small number of samples successfully genotyped precluded further statistical analysis.
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4.4

Discussion

In general, outbreaks of Q fever occur at local or regional scales rather than at the
national level or international level (Schimmer et al., 2008; Signs et al., 2012; Bjork et al.,
2014). Moreover, infection with C. burnetii is not always expressed as clinical Q fever in
the human or ruminant hosts. Identifying a predisposition to infection with C. burnetii in
the host species in a particular geographic location can facilitate resource allocation for
education and interventions as well as help to focus surveillance strategies for both
human and animal populations. In this study, a trend toward increased odds of infection
with C. burnetii was identified for does from PHPD 9, which encompasses 12 counties in
the southeastern part of Indiana. Three of the counties with the largest populations of
goats in 2012 (Harrison, Jefferson and Ripley counties) are located within PHPD 9. This
study included 2 farms from Harrison County, both of which had goats that tested
positive for C. burnetii by PCR, but neither Jefferson County nor Ripley County was
represented. The other counties PHPD 9 with positive goats, Decatur and Scott Counties,
were each represented by a single farm with positive does.
Limitations in this study derive in part from the use of a convenience sample.
Relying on voluntary participation can affect both the sample size and how well the
sample reflects the population of interest. Small sample size is an important limitation
of this study. Approximately half of the counties sampled (n=24) are represented by a
single herd of goats. This may not be as problematic for counties with a small number of
goats/farms such as Perry county (165 goats in 2012), but is of concern for counties with
a large goat population such as Elkhart and Daviess counties (2618 and 901 goats
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respectively). The presence of C. burnetii in counties with only a single farm sampled
could have been missed, resulting in underestimation of prevalence for that PHPD. This
may be the case for PHPD 7, although 5 farms from that PHPD were sampled.
Alternately, if the herd tested was positive for the presence of C. burnetii, the
prevalence for the PHPD would have been overestimated. The limited number of
counties with more than 1 herd tested also precluded the estimation of prevalence at
the county level. All PHPDs had at least 5 herds tested which allowed statistical
evaluation, but limited the precision of prevalence and odds ratio estimates as
illustrated in the wide confidence intervals in Tables 2, 3, and 4. The lack of statistical
significance for the increased odds of a doe testing positive for C. burnetii in PHPD 9 may
also be related to small sample size.
An additional challenge of a convenience sample is the introduction of sampling
bias. In this study, the sample did not accurately reflect the spatial distribution of the
study population, introducing bias into the results. A larger sample size would not have
necessarily corrected this bias, but combining a larger sample size with the goal of
recruiting farms to the study in numbers proportionate to the number of farms present
in each county, a sampling proportionate to size strategy, may have helped. For example
La Grange County had 121 farms which owner goats in 2012, 4.2% of the total farms
with goats in Indiana. In a study with a target sample size of 200 farms, 8 of those farms
would be recruited from LaGrange County. Convenience sampling would still play a role
in recruitment within the county, but this recruitment method would result in a more
geographically representative sample.
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Goats in this sample were not necessarily geographically restricted, resulting in a
third limitation of this study. Of the 94 farms included in the study, 78 (83.0%) owned
goats for the purpose of showing and 45 (47.9%) bred their does to bucks that they did
not own by natural insemination. Of these 45 farms, 37 (82.2%) transported the does to
the premises where the bucks were housed for breeding. Goats do not tend to stay in
one location and this should be accounted for in future studies.
SNP analysis to identify the STs of C. burnetii circulating within Indiana was
successful in only 3 samples although a probable ST was identified in an additional
sample. This lack of success was in part due to contamination of many of the vaginal
swab samples by the plasmid designed to evaluate the analytic sensitivity of the realtime PCR utilized in this study. A real-time PCR designed to target the vector portion of
the plasmid genome was used to determine that the positive vaginal samples reported
as positive herein were free of plasmid contamination. In addition to the challenge of
contamination, a low amount of target DNA for the SNP analyses in the submitted
samples may also be contributing the low number of samples successfully genotyped.
The PCR utilized in this study targets the IS1111 transposon. This region of the C.
burnetii genome is present in multiple copies, but there is variation in the number of
copies present by strain (Klee et al., 2006). The target genes utilized for SNP analysis are
single copy and thus detection of high numbers of the IS1111 transposon in a DNA
sample does not guarantee that there are many copies of the SNP targets present in the
same sample. This was a similar challenge when sequence typing of C. burnetii samples
from bulk tank milk samples was undertaken (Bauer et al., 2015). Bulk tank milk samples
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are contributed to by multiple individuals and thus are likely to contain larger quantities
of bacteria than the samples in the current study, which came from individual goats. The
samples where a sequence type was successfully identified are consistent with a
previous study documenting ST8 as the most common strain of C. burnetii in goats in the
United States (Pearson et al., 2014).
C. burnetii was identified in goats from all regions of Indiana and all PHPDs with
the exception of PHPD 7. There was a predisposition for does in the southeastern region
of the state, PHPD 9, to test positive for C. burnetii. This region would be a good choice
for research focused at a finer geographic scale, particularly investigations of patterns of
transmission between goats and other species. PHPD 9 would also be a good choice for
pilot testing educational measures and preventive interventions focusing upon
producers, veterinarians and physicians.

81
4.5

Bibliography

Bauer, A. E., S. Olivas, M. Cooper, H. Hornstra, P. Keim, T. Pearson and A. J. Johnson,
2015: Estimated herd prevalence and sequence types of Coxiella burnetii in bulk
tank milk samples from commercial dairies in Indiana. BMC Veterinary Research,
11, 186.
Beall, J., J. Burkman, J. Butwin, P. Britton, J. Howell, P. Pontones, S. Richards and S.
Wayne, 2002: 2000 Indiana report of infectious diseases. H. Messersmith (ed.),
Indiana Report of Infectious Diseases. Indiana State Department of Health
Epidemiology Resource Center, Indianapolis, Indiana.
http://www.in.gov/isdh/20667.htm. Accessed 25 September 2015.
Beall, J., J. Burkman, J. Butwin, P. Britton, T. Kerr, J. Howell, P. Pontones, S. Richards and
W. Staggs, 2004: 2001 Indiana report of infectious diseases. H. Messersmith (ed.).
Indiana State Department of Health, Epidemiology Resource Center, Indianapolis,
Indiana. http://www.in.gov/isdh/21124.htm. Accessed 25 September 2015.
Beall, J., J. Burkman, T. Kerr, J. Howell, C. Pearcy, P. Pontones, S. Richards, W. Staggs and
M. Wilkinson, 2006a: 2002 Indiana report of infectious diseases. P. Pontones
(ed.). Indiana State Department of Health, Epidemiology Resource Center,
Indianapolis, Indiana. http://www.in.gov/isdh/21125.htm. Accessed 25
September 2015.
Beall, J., J. Burkman, T. Kerr, J. Howell, C. Pearcy, P. Pontones, S. Richards, W. Staggs and
M. Wilkinson, 2006b: 2003 Indiana report of infectious diseases. P. Pontones
(ed.). Indiana State Department of Health, Epidemiology Resource Center,
Indianapolis, Indiana. http://www.in.gov/isdh/21127.htm. Accessed 25
September 2015.
Beall, J., J. Burkman, T. Kerr, J. Howell, C. Pearcy, P. Pontones, S. Richards, W. Staggs and
M. Wilkinson, 2007a: 2004 Indiana report of infectious diseases. P. Pontones
(ed.). Indiana State Department of Health, Epidemiology Resource Center,
Indianapolis, Indiana. http://www.in.gov/isdh/21128.htm. Accessed 25
September 2015
Beall, J., J. Burkman, T. Kerr, J. Howell, C. Pearcy, P. Pontones, S. Richards, W. Staggs and
M. Wilkinson, 2007b: 2005 Indiana report of infectious diseases. In: P. Pontones
(ed.). Indiana State Department of Health, Epidemiology Resource Center,
Indianapolis, Indiana. http://www.in.gov/isdh/23584.htm. Accessed 25
September 2015.

82
Beall, J., J. Burkman, T. Kerr, J. Howell, C. Pearcy, P. Pontones, S. Richards, W. Staggs and
M. Wilkinson, 2007c: 2006 Indiana report of infectious diseases. P. Pontones
(ed.). Indiana State Department of Health, Epidemiology Resource Center,
Indianapolis, Indiana. http://www.in.gov/isdh/24269.htm. Accessed 25
September 2015.
Bjork, A., N. Marsden-Haug, R. J. Nett, G. J. Kersh, W. Nicholson, D. Gibson, T. Szymanski,
M. Emery, P. Kohrs, D. Woodhall and A. Anderson, 2014: First reported
multistate human Q fever outbreak in the United States, 2011. Vector-borne and
Zoonotic Diseases, 14, 111 - 117.
Centers for Disease Control and Prevention (CDC)., 2013: Q fever: Statistics and
epidemiology. http://www.cdc.gov/qfever/stats/index.com. Accessed 14
February 2014.
Drancourt, M. and D. Raoult, 2005: Genus I. Coxiella. In: D. J. Brenner, N. R. Krieg, J. T.
Staley and G. M. Garrit (eds.), Bergey's Manual of Systematic Bacteriology.
Springer, New York. 237-241.
Glazunova, O., V. Roux, O. Freylikman, Z. Sekeyova, G. Fournous, J. Tyczka, N.
Tokarevich, E. Kovacava, T. Marrie and D. Raoult, 2005: Coxiella burnetii
genotyping. Emerging Infectious Diseases, 11, 1211-1217.
Hornstra, H. M., R. A. Priestley, S. M. Georgia, S. Kachur, D. N. Birdsell, R. Hilsabeck, L. T.
Gates, J. E. Samuel, R. A. Heinzen, G. J. Kersh, P. Keim, R. F. Massung and T.
Pearson, 2011: Rapid typing of Coxiella burnetii. PLOS One, 6. 1-9.
Klee, S. R., H. Ellerbrok, J. Tyczka, T. Franz and B. Appel, 2006: Evaluation of a real-time
PCR assay to detect Coxiella burnetii. Annals of the New York Academy of
Science, 1078, 563-565.
Merck and Company 2005: The Merck Veterinary Manual, Whitehouse Station, New
Jersey, USA. 1103-1104.
Oyston, P. C. and C. Davies, 2011: Q fever: the neglected biothreat agent. J Med
Microbiol, 60, 9-21.
Panning, M., J. Kilwinski, S. Greiner-Fischer, M. Peters, S. Kramme, D. Frangoulidis, H.
Meyer, K. Hennin and C. Drosten, 2008: High throughput detection of Coxiella
burnetii by real-time PCR with internal control system and automated DNA
preparation. BMC Microbiology, 8. 77.

83
Parker, N. R., J. H. Barralet and A. M. Bell, 2006: Q fever. The Lancet, 367, 679-688.
Pearson, T., H. M. Hornstra, R. Hilsabeck, L. T. Gates, S. M. Olivas, D. M. Birdsell, C. M.
Hall, S. German, J. M. Cook, M. L. Seymour, R. A. Priestley, A. V. Kondas, C. L.
Clark Friedman, E. P. Price, J. M. Schupp, C. M. Liu, L. B. Price, R. F. Massung, G. J.
Kersch and P. Keim, 2014: High prevalence and two dominant host-specific
genotypes of Coxiella burnetii in U.S. milk. BMC MIcrobiology, 14. 41.
Raoult, D., T. J. Marrie and J.-L. Mege, 2005: Natural history and pathophysiology of Q
fever. Lancet Infectious Disease, 5, 219 - 226.
Rodolakis, A., M. Berri, C. Hechard, C. Caudron, A. Souriau, C. C. Boudier, B. Blanchard, P.
Camuset, P. Devillechase, J. C. Natorp, J. P. Vadet and N. Arricau-Bouvery, 2007:
Comparison of Coxiella burnetii shedding in milk of dairy bovine, caprine, and
ovine herds. Journal of Dairy Science, 90, 5352-5360.
Roest, H. I. J., J. J. H. C. Tilburg, W. van der Hoek, P. Vellema, F. G. van Zijderveld, C. H.
W. Klaasens and D. Raoult, 2011: The Q fever epidemic in The Netherlands:
history, onset, response and reflection. Epidemiol. Infect., 139, 1-12.
Schimmer, B., G. Morroy, F. Dijkstra, P. M. Schneeberger, G. Weers-Pothoff, A. Timen, C.
Wijkmans and W. van der Hoek, 2008: Large, ongoing Q fever outbreak in the
south of the Netherlands, 2008. Euro Surveill, 13, pii=18939.
Signs, K. A., M. G. Stobierski and T. N. Gandhi, 2012: Q fever cluster among raw milk
drinkers in Michigan, 2011. Clinical Infectious Diseases, 55. 1387-1389.
Staggs, W., S. Richards, J. Svendson, S. Sczesny, K. Ryker, D. Hazen, J. House and A.
ThurdeKoos, 2009: 2007 Indiana report of infectious diseases. In: J. Michael (ed.).
Indiana State Department of Health, Epidemiology Resource Center, Indianapolis,
Indiana. http://www.in.gov/isdh/24765.htm. Accessed 25 September 2015.
United States Department of Agriculture (USDA), 2012: Census of Agriculture 2012.
http://www.agcensus.usda.gov/Publications/2012/Full_Report/Volume_1,_Chap
ter1_US/st99_1_028_031.pdf. Accessed 3 September 2015.

84

Figure 4-1. Public health preparedness district and regional boundaries in Indiana. Public
Health Preparedness districts are identified by number while regions are identified by
color.
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Figure 4-2. Geographic distribution of the Indiana goat population in 2012 based on the
2012 National Census of Agriculture (USDA, 2012).
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Table 4-1. Number of goats by PHPD and region of Indiana in 2012 and the study sample

Region

Total

Percent of

Goats in

Percent of

Goats

Indiana Goats

Sample

Sampled Goats

1

1502

3.9

32

4.9

2

4595

11.9

32

4.9

3

4818

12.5

141

21.7

10915

28.3

205

31.5

4

4054

10.5

75

11.6

5

3734

9.7

89

13.7

6

4444

11.5

86

13.2

7

2953

7.6

31

4.8

15185

39.3

281

43.3

8

2768

6.9

33

5.1

9

6338

16.4

74

11.4

10

3426

8.9

56

8.6

Total

12532

32.4

163

25.1

State Total

38632

Northern

PHPD

Total
Central

Total
Southern

649
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Table 4-2. Individual level prevalence estimates by PHPD and region
Region

PHPD

Positive

Negative

Total

Estimated Prevalence

95% CI

Northern

1

2

30

32

6.2%

1.7-20.1%

2

4

28

32

12.5%

5.0-28.1%

3

15

126

141

11.9%

7.3-18.7%

21

184

205

10.2%

6.7-15.1%

4

9

66

75

12.0%

6.4-21.3%

5

8

81

89

9.0%

4.6-16.7%

6

6

80

86

7.0%

3.2-14.4%

7

0

31

31

0.0%

0-11.0%

23

258

281

8.2%

5.5-12.0%

8

2

31

33

6.1%

1.7-19.6%

9

16

58

74

20.3%

12.7-

Total
Central

Total
Southern

30.8%
10
Region Total

4

52

56

7.1%

2.8-17.0%

22

141

163

13.5%

9.1-19.6%

88
Table 4-3. Herd level prevalence estimates by PHPD and region
Region

PHPD

Positive

Negative

Total

Estimated Prevalence

95% CI

Northern

1

2

4

6

33.3%

9.7-70%

2

2

4

6

33.3%

9.7-70%

3

4

15

19

21.0%

8.5-43.3%

8

23

31

25.8%

13.7-43.2%

4

4

8

12

33.3%

13.8-60.9%

5

5

8

13

38.5%

17.7-64.5%

6

2

8

10

20.0%

5.7-51%

7

0

5

5

0.0%

0-43.4%

11

29

40

27.5%

16.1-42.8%

8

2

4

6

33.3%

9.7-70.0%

9

4

5

9

44.4%

18.9-73.3%

10

2

6

8

25.0%

7.1-59.0%

8

15

23

34.8%

18.8-55.1%

Region Total
Central

Region Total
Southern

Region Total
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Table 4-4. Comparing the odds of an individual doe testing positive for C. burnetii in
different PHPDs. PHPD 1 was used for comparison as the referent district and PHPD 7
did not have any does test positive for C. burnetii.
PHPD

OR

95%CI

p

1

NA

NA

NA

2

2.14

0.36-12.63

0.40

3

1.78

0.38-8.23

0.46

4

2.04

0.41-10.05

0.38

5

1.48

0.30-7.37

0.63

6

1.12

0.21-5.88

0.89

7

--

--

--

8

0.97

0.13-7.32

0.98

9

4.14

0.89-19.20

0.07

10

1.15

0.20-6.67

0.87
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CHAPTER 5.

EVALUATION OF THREE POTENTIAL RISK FACTORS FOR INFECTION WITH
COXIELLA BURNETII IN GOATS IN INDIANA

5.1

Introduction

Coxiella burnetii is the causative organism of Q fever, a zoonotic disease that can
lead to reproductive losses in ruminants and acute influenza-like disease, cardiovascular
disease, chronic fatigue syndrome and pregnancy loss in people. The small cell variant of
C. burnetii is environmentally resilient, allowing it to persist in a variety of environments
(Kersh et al., 2010b), be carried as a fomite (Kersh et al., 2013) and be transmitted by
wind (Tissot-Dupont et al., 2004). In addition, a wide variety of animal species have been
documented to be infected by C. burnetii (Stein & Raoult, 1999; Cairns et al., 2007;
Cooper et al., 2011; Kersh et al., 2010a; Reusken et al., 2011; Davoust et al., 2014).
C. burnetii can be considered to be a re-emerging zoonotic pathogen, defined as a
disease or agent known to exist, but exhibiting an increase in incidence or range,
(Morens et al., 2004). In some situations, C. burnetii also meets conditions that play a
role in disease emergence such as environmental encroachment and an increased
frequency of interactions between people and wildlife (Morens et al., 2004). An
example of this is the recognition of the 3-toed sloth as a likely vector for a unique strain
of C. burnetii in French Guiana (Davoust et al., 2014). However, the nonspecific clinical
signs of infection with C. burnetii in both humans and animals make the
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diagnosis of Q fever difficult and what could be viewed as re-emergence in some
settings may simply be the result of underdiagnosis. These nonspecific clinical signs have
contributed to the historically challenging nature of epidemiologic studies of C. burnetii.
Despite the wide range of host species and outbreaks of Q fever associated with
other species (Pinsky et al., 1991; Stein & Raoult, 1999; Davoust et al., 2014), domestic
ruminants are considered to be the main reservoir for human infection with C. burnetii.
Small ruminants, in particular goats, have been associated with recent human outbreaks
of Q fever in Europe and the United States (Schimmer et al., 2010; Bjork et al., 2014).
Potential risk factors for C. burnetii infection in goats have been evaluated in the context
of commercial farms (Schimmer et al., 2011). One of the inclusion criteria for that study
was a herd size of at least 100 goats, but the median herd size was 782 goats. The
seroprevalence of C. burnetii was 21.4% in the 2828 individual goats tested. Risk factors
that were identified included: Other goat farms within 8km with C. burnetii in bulk tank
milk, high density of cattle within the community, covering air spaces in the barns
(either to control pests or as windbreaks), the presence of cats within the housing area
and the use of artificial insemination. A herd size of 800 goats or more was also
identified as a risk factor for C. burnetii infection at both the individual and herd levels
(Schimmer et al., 2011).
While the seroprevalence of C. burnetii has been evaluated in goats at the state
level in the United States (Sondgeroth et al.; 2013, Baker & Pithua, 2014), little work has
been done investigating potential risk factors for C. burnetii infection in this species.
Although there is regional variation, the 2012 Census of Agriculture reported 2,621,514
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goats and 128,456 premises owning goats in the United States, resulting in an overall
average of 20.4 goats per herd. In Indiana, 38,632 goats and 2883 premises were
reported in 2012, resulting in an overall average of 13.4 goats per farm (USDA, 2012).
Although the majority of the risk factors for C. burnetii identified by Schimmer et al are
not related to herd size, there is the potential for variation in these risk factors
depending on herd size and geographic location.
The purpose of this study was to investigate the role of 3 potential risk factors
for C. burnetii infection in goats in Indiana. Infection with C. burnetii was defined in 2
ways: seropositivity for anti-C. burnetii antibodies through use of a commercially
available enzyme linked immunosorbent assay (ELISA) and shedding of C. burnetii as
detected by polymerase chain reaction (PCR) targeting the IS1111 transposon. These
diagnostics were evaluated separately because seropositivity implies exposure to C.
burnetii but not necessarily active infection in the absence of paired sera while shedding
of C. burnetii DNA indicates active infection. The predictors of interest were: The
presence of cattle, sheep or camelids on the farm, indoor housing and a history of
reproductive events on the farm.
5.2

Materials and methods

5.2.1 Population of interest, recruitment and data collection
Individuals and herds in this study were identified as part of a cross-sectional,
convenience sampled study to estimate the prevalence of C. burnetii in goats in Indiana.
Goat does over 1 year of age and not pregnant at the time of sampling were chosen for
inclusion in the study. Based on the reported 2883 premises with goats in Indiana (USDA,
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2012) and utilizing an estimated herd level seroprevalence and DNA shedding
prevalence of 50% and 95% confidence, a recruitment goal of 95 farms was identified. In
order to determine the number of does to sample within a herd, an expected within
herd seroprevalence of 40% and expected DNA shedding prevalence of 50% within an
infected herd were utilized to calculate a sampling goal of 10 does per herd in herds
with 100 does or fewer. In herds with more than 10 does meeting the inclusion criteria,
the producer selected the individual does to be sampled. In herds with fewer than 10
does meeting the eligibility criteria, all eligible does were sampled.
Goat herds in Indiana were identified through personal communication at shows,
the use of breed organization directories and through internet searches between May of
2012 and August of 2014. Producers were approached through face-to-face personal
communication, e-mail and telephone conversations. The template for e-mail contacts
can be found in Appendix A. Sample collection was then performed at shows or at
scheduled farm visits.
Samples of blood, milk, vaginal mucus, and feces were collected on the same day
from each doe selected from a given farm. The exception to this was a single farm that
was recruited at a show. The does present at the show were sampled there and
additional does were sampled at a subsequent farm visit. Sample collection techniques
were approved by the Purdue Animal Care and Use Committee (protocol 1205000641)
and were performed as follows: Blood samples were collected via jugular venipuncture
by one of the investigators; milk samples were collected by the owner or an investigator
utilizing the normal hygienic practices for milking at the farm; sterile cotton-tipped
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plastic swabs were used by an investigator to collect samples of vaginal mucus; to
ensure that the fecal samples represented a single doe, samples were collected from
the rectum by an investigator unless the doe defecated at the time of sampling, in which
case the immediately voided sample was collected. Samples were transported in coolers
with ice or icepacks from the sampling location to Purdue University for laboratory
analysis.
Two types of questionnaire, as approved by the Purdue University Institutional
Review Board were presented to the owners of farms included in the study. These
questionnaires are reproduced in Appendices B and C. The first (Appendix B) collected
information about the farm and herd in general. The second (Appendix C) collected
information about each specific doe included in the study. Topics covered in these
questionnaires included:
1. Basic farm information including location (by county and zip code), length of
ownership of the farm, length of ownership of goats, number and type of other animals
present on the farm.
2. Demographic information on the goats owned including number of goats, breeds of
goats, purpose of goats (milk production, meat production or fiber production), gender
and ages of the goats and the number of goats introduced to the herd on a regular basis.
3. Husbandry information including outdoor versus indoor housing, indoor floor surface
and use of veterinary care.
4. Reproductive disease history including abortions, stillbirths and weak kids for both
the individual does and the farms as a whole.
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5.2.2 Diagnostic methodology
Upon return to the laboratory at Purdue University, blood samples were
centrifuged at 4000 rpm for 10 minutes to separate serum. After centrifugation, 1 to 2
ml of serum were removed from the collection tube and stored in cryotubes at -20oC
pending analysis. The Idexx Chekit Q-fever enzyme linked immunosorbent antibody test
(ELISA) (trademark IDEXX Laboratories, Hoofddorp, the Netherlands) was utilized for
evaluation of the presence of anti-C. burnetii antibodies. This ELISA detects antibodies
to either phase I or phase II antigen (personal communication with customer service
representative on the IDEXX Livestock and Poultry Team) with a reported sensitivity of
100% and specificity of 100%. When this test was compared with complement fixation
in 81 samples, there was a correlation of 98% between the 2 types of tests (Schalch et
al., 1998). The sensitivity and specificity of the ELISA were independently estimated at
the National Veterinary Services Laboratory using an expectation-maximization
algorithm. The estimated sensitivity from this analysis was 97% and the estimated
specificity was 100% (95% CI: 90-100%) (Emery et al., 2014). Samples were tested
following the manufacturer’s protocol using positive and negative controls provided by
the manufacturer. A positive ELISA sample was defined by demonstration of an optical
density (OD) at least 40% of that of the positive controls included with each assay. A
negative sample was defined as one that demonstrated an OD less than 30% of that of
the positive control after correction by subtraction of the OD of the negative control.
Samples with OD between 30 and 40% of the positive control after correction by
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subtraction of the negative control were defined as indeterminate and retested. None
of the samples remained indeterminate after subsequent testing.
Upon return to the laboratory at Purdue University, milk, vaginal swab and fecal
samples were stored at -20oC pending DNA extraction. If DNA extraction was performed
within 24 hours of collection milk samples were stored under refrigeration. DNA was
extracted from the milk samples utilizing a Qiagen DNeasy Blood and Tissue Kit
(trademark Qiagen, Valencia, California) as previously described (Bauer et al., 2015).
DNA samples were stored at -20oC prior to real time quantitative polymerase chain
reaction (PCR) testing.
A Qiagen DNeasy Blood and Tissue Kit (trademark Qiagen, Valencia, California)
protocol for buccal DNA extraction was utilized for DNA extraction from the vaginal
swabs. Swabs were suspended in 400l sterile PBS. After suspension, 20l Proteinase K
and 400l Buffer AL were then added to each sample. Swabs and reagents were mixed
by vortex, incubated at 56oC for 10 minutes and briefly centrifuged prior to adding 400l
ethanol to the lysate. The lysate was filtered through columns and washed with buffers
AW1 and AW2. Buffer AE (150l) was added to the columns for the final elution. DNA
samples were stored at -20oC prior to PCR testing.
A QIAamp DNA Stool Mini Kit (trademark Qiagen, Valencia, California) was
utilized for DNA extraction from fecal samples. Individual sample aliquots of 200mg of
feces were used for each extraction. One ml of Inhibitex Buffer was added to each
sample, vortexed to mix and incubated at 95oC for 5 minutes prior to centrifugation.
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After centrifugation, 200l of supernatant was added to 15l Proteinase K and 200l of
Buffer AL was added. Samples were vortexed and incubated at 70 oC for 10 minutes.
After incubation, 200l ethanol was added to the lysate, mixed and 600l of the lysate
was filtered through columns and washed with buffers AW1 and AW2. Buffer ATE
(200l) was used for the final elution. DNA samples were stored at -20oC prior to PCR
testing.
Real time quantitative PCR was used to identify the presence of an 86 base pair
(bp) region of the C. burnetii IS1111 transposon (Panning et al., 2008) as previously
described (Bauer et al., 2015). A Stratagene Mx3000P qPCR system (trademark Agilent
Technologies, Santa Clara, CA) was utilized for real-time PCR and results were collected
in MxPro (trademark Agilent Technologies, Santa Clara, CA). PCR was repeated for
samples demonstrating a cycle threshold (CT) value and samples with an average CT
value less than or equal to 36.5 were defined as positive for analytic purposes.
Individuals testing positive for C. burnetii DNA from any of the 3 samples were defined
as positive individuals for analytic purposes.
5.2.3 Statistical analysis
Two types of cases were defined. Seropositive cases had an OD greater than or
equal to 40% of that of the controls as described above, indicating that an immune
response against C. burnetii was mounted by the doe at some point in her life. DNA
positive cases had an average CT values less than or equal to 36.5 from any of the
samples tested by PCR, indicating active shedding of C. burnetii at the time of sampling.
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Logistic regression models were constructed in SPSS (SPSS Statistics for Windows,
Version 22.0. Armonk, NY: IBM Corp Released 2013) to evaluate the effects of 3
predictors of interest on these outcomes. The predictors of interest were: Housing in
confinement, the presence of other ruminants (cattle, sheep or camelids) on the farm
and the past occurrence of reproductive events in the goats on the farm. For the
purposes of the current study, confinement was defined as being housed indoors with
very limited to no outdoor access. Since C. burnetii is primarily transmitted by inhalation,
being housed primarily indoors could increase the chances of a doe encountering the
organism in dust within the barn as compared to living in an outdoor environment with
a greater degree of air circulation. Cattle and sheep are known reservoir species for C.
burnetii (Rodolakis et al, 2007). Llamas and alpacas are kept as livestock guardian
animals. The presence of other reservoirs on the farm and potentially in close proximity
to goats would be expected to facilitate transmission of C. burnetii. Does living on farms
where reproductive events have occurred could be expected to have a greater risk of
exposure to C. burnetii in the environment than does living on farms where reproductive
events have not occurred. For the purposes of this study, a reproductive event was
defined as abortion, stillbirth or weak kids at the time of parturition.
Covariates to be included in model construction were defined for each of the
predictors of interest through the use of causal diagrams (Dohoo et al., 2009). Figure 1
illustrates the causal diagram initially constructed to identify the covariates of interest
for each predictor of interest. Backward selection based on a 10% change in the odds
ratio for the predictor of interest was utilized to select influential confounders.
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5.3

Results

5.3.1 Study sample and variables of interest
A total of 654 does representing 95 farms were included in the study. Serologic
results were available for 613 does. At least one type of sample was tested for C.
burnetii DNA in all 654 does (Table 5.1). Milk, vaginal discharge and fecal samples were
all tested in 349 does. Of the does where all 3 types of samples were not collected, 31
does provided both vaginal and milk samples but not fecal samples, 226 does provided
both vaginal and fecal samples but not milk samples and 1 doe provided both milk and
fecal samples but a vaginal sample was not collected. Forty-five does had only a single
sample type tested for C. burnetii DNA. Serum samples from 23 does (3.8%) tested
positive for anti-C. burnetii antibodies. A total of 49 does (7.5%) tested positive for C.
burnetii DNA by at least 1 route of shedding.
There was information available for 2 of the 3 predictors of interest for all 654 of
the does sampled (Table 5.2). Two-hundred-forty-six does (40.4%) lived on farms where
other ruminants were housed. Of these 246, 118 (48.0%) lived on farms where cattle
were the only other ruminant species, 59 (20%) lived on farms where sheep were the
only other ruminant species and 41 (16.7%) lived on farms where camelids were the
only other ruminant species. Cattle and sheep were both present on the farms where 25
does lived (10.2%), cattle and camelids were present on the farms where 3 does lived
(1.2%). No does lived on farms where both sheep and camelids were present. Of 654
does sampled, 626 (95.7%) lived on farms where reproductive events had occurred.
Housing information was available for 644 of the 654 does sampled. Seventy-one does
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(11.0%) were housed primarily indoors and 573 does (89.0%) had outdoor access at
least 50% of the time. Of these 583 does, 211 (36.8%) were housed primarily outdoors.
Potential confounding factors were identified for all of the predictors of interest
in this study. For indoor housing, breed type and the presence of other ruminants on
the farms were identified as potential confounders. For cattle, sheep or camelids on the
farm, breed type and herd size were identified as potential confounders. For herd level
reproductive events, the presence of cattle, sheep or camelids was identified as a
potential confounding factor.
5.3.2 Model building
Information on housing was available for 606 of the 613 does tested by ELISA
(Table 5.2). Seventy of these does were housed primarily indoors (11.5%). Only 1 of the
does tested positive for anti-C. burnetii antibodies by ELISA. All 613 of the does tested
by ELISA had information about the presence of cattle, sheep or camelids on the farm
available. Cattle, sheep or camelids were present on the farms where 231 does lived
(37.7%). Three of these does tested positive for anti-C. burnetii antibodies by ELISA.
Information on the history of reproductive events on the farm was available for all 613
of the does tested by ELISA. Five-hundred-eighty seven does (95.6%) lived on a farm
where reproductive events had occurred. All of the does that tested positive for anti-C.
burnetii antibodies resided on farms with a history of reproductive events. A value of 1
was added to each of the cells to attempt odds ratio estimation. Table 5.2 also includes
the univariate analyses of the predictors of interest. The presence of cattle, sheep or
camelids on the farms was the only predictor of interest that was statistically
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significantly related to seropositivity for C. burnetii. Does housed on farms with these
other species present demonstrated a 5-fold decrease in the odds of testing positive for
anti-C. burnetii antibodies.
Three separate logistic regression models were constructed to evaluate the
relationship between each of the predictors of interest and seropositivity for C. burnetii.
Table 5.3 provides information on the covariates included in the final models after
backward selection was implemented. In these models, only the presence of other
ruminants on the farm had a statistically significant association with the detection of
anti-C. burnetii antibodies in individual does (OR = 0.23, 95% CI: 0.07 – 0.79, p = 0.020).
Information on housing was available for 644 does tested for C. burnetii by PCR
(Table 5.2). Seventy-one of these does (11.0%) were housed primarily indoors, including
6 of the 49 does positive for shedding C. burnetii DNA (12.2%). Information on the
presence of cattle, sheep or camelids on the farm was available for all 654 does. Twohundred and forty-six of these does (37.6%) lived on farms that housed other species of
domestic ruminants and 7 of the 49 positive does (14.3%) were among this group.
Information about the history of reproductive events on the farm was available for 654
does. Six-hundred-twenty-six of the does (95.7%) lived on farms where a reproductive
event had occurred. Forty-seven of the does positive for shedding C. burnetii DNA
(95.9%) lived on a farm where a reproductive event had occurred. Table 5.2 details the
univariate analyses of the predictors of interest. The presence of cattle, sheep or
camelids on the farms was the only predictor of interest that was statistically
significantly related to shedding of C. burnetii, with does living on farms with these
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other species present demonstrating a 70% decrease in the odds of testing positive for
anti-C. burnetii antibodies.
Three separate logistic regression models were constructed to evaluate the
relationship between each of the predictors of interest and shedding of C. burnetii by
individual does. Table 5.4 provides information on the covariates included in the final
models after backward selection was implemented. In modelling the presence of cattle,
sheep or camelids on the farm, neither of the proposed confounders was influential and
thus the crude odds ratios are reported. In these models, only the presence of other
ruminants on the farm had a statistically significant association with shedding of C.
burnetii with a 3.8-fold decrease in the odds of C. burnetii DNA being detected in does
living on farms with cattle, sheep or camelids present as compared to does living on
farms without these species present (OR = 0.26, 95% CI: 0.11 – 0.58, p = 0.001).
5.4

Discussion

This study utilized both molecular and serologic data to evaluate factors
potentially associated with C. burnetii infection. The use of both molecular and serologic
diagnostics to evaluate potential risk factors for C. burnetii infection is a unique aspect
of this study. The development of culture techniques (Omsland et al., 2009) has
improved the understanding of the genetics of C. burnetii, leading to molecular
diagnostic methods that are both rapid and sensitive. In addition, understanding the
biphasic nature of the immune response to C. burnetii has allowed the development of
sensitive methods for detection of exposure to the bacteria through serology (Emery et
al., 2012).
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Due to the lack of seropositive does on farms where reproductive events had not
occurred, history of reproductive events within the herd was only included as a
predictor in the model of DNA shedding. This does not mean that a history of
reproductive events on the farm is negligible in relationship to exposure to C. burnetii.
Rather, this lack of seropositive does on farms without a history of reproductive events
warrant further investigation. However, a sample with a greater prevalence of anti-C.
burnetii antibodies is needed and a case-control design would be more appropriate.
Further investigation into the relationship between prior reproductive events and
exposure to C. burnetii would also benefit from defining the history of reproductive
events in a time-restricted manner (i.e. within the past 2 years) as events that occurred
more recently would be expected to have a greater likelihood of infecting previously
unexposed does. However, several other pathogens can result in late term abortion in
goats, including Toxoplasma gondii, Chlamydophila abortus, Listeria monocytogenes,
Brucella melitensis and Leptospira interrogans (serovars Grippotyphosa and Pomona)
(Merck, 2005). Coinfection with C. burnetii, T. gondii, and C. abortus has been
documented in cases of abortion in goats (Hazlett et al., 2013). A history of reproductive
events may be tied to another pathogen even if C. burnetii is identified in a doe or herd
and it is possible that even in an ideal sample the history of reproductive events on a
farm may not be associated with increased odds of detecting C. burnetii.
Indoor housing did not prove to be a statistically significant predictor in
relationship to either seropositivity or DNA shedding. The small sample size, in particular
the low prevalence of C. burnetii in this sample, likely precluded conclusions being
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drawn as to the effect of this variable. Indoor housing was chosen as a risk factor for
exploration because inhalation is the main route of C. burnetii transmission and goats
housed in indoor spaces may be exposed to higher concentrations of C. burnetii in dust
that goats that are outdoors. The use of wind curtains or wind breaks was previously
identified as a risk factor for seropositivity in goats (Schimmer et al., 2011) and C.
burnetii DNA has been identified in goat pens up to 1 year after an outbreak (Kersh et al.,
2013). In this study, the goats were mainly kept in small herds (median herd size 20
goats) and the largest herd (150 goats) had equal access to indoor and outdoor
environments. Further studies on the role of indoor housing may benefit from focusing
on commercial operations which are more likely to house goats in a truly indoor facility,
have larger herd sizes, and utilize wind screens or similar measures for protection from
adverse weather or wildlife.
The presence of cattle, sheep or camelids on the farm was associated with a
statistically significant decrease in the odds of both testing positive for anti-C. burnetii
antibodies (5-fold decrease) and shedding of C. burnetii DNA (4-fold decrease) in this
study. The direction of this association is surprising, but may be due to a tendency for
farms with a large variety of animal species to have fewer numbers of each species.
However, the size of the goat herd on farms with other ruminants ranged from 1 to 150
goats which is not consistent with the explanation of a smaller goat herd size on farms
with cattle, sheep or camelids in addition to goats. Alternately, species dominant strains
of C. burnetii may not transmit as efficiently between ruminant species. There has been
documentation of the proposed cattle dominant sequence type of C. burnetii (ST20) in
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goat milk (Pearson et al., 2014) and the proposed goat dominant sequence type (ST8) in
cattle bulk tank milk samples (Bauer et al., 2015). An ecological phenomenon called the
dilution effect provides another potential explanation. A dilution effect occurs when the
presence of a wide variety of potential host species with a poor ability to transmit the
pathogen of interest in addition to more competent host species decreases the risk of
pathogen transmission (Schmidt & Ostfeld, 2001). For density-dependent pathogens,
adding alternate host species can decrease the risk of disease transmission if between
species transmission occurs less frequently than within species transmission (Keesing et
al., 2006). However, more work is needed to elucidate transmission patterns for C.
burnetii between species in a community such as a farm.
Although not defined as a predictor of interest in this study, one covariate was
influential in relationship to the predictors of interest and may be worth evaluating as a
risk factor in future studies. Whether or not a doe was from a meat breed as compared
to a non-meat breed was included as a covariate in 4 of the 6 models as a surrogate for
unmeasured intrinsic factors (e.g. immune function, differences in mammary structure
at the microscopic level) and unmeasured extrinsic factors (e.g. density, diet variation)
when compared with other types of breeds. Meat breed was retained as a covariate in
the models in which indoor housing was the predictor of interest and in the model
evaluating the relationship between seropositivity and the presence of cattle, sheep or
camelids on the farm. Although not within the scope of this study, investigating breed
and breed class variation in factors such as leukocyte numbers, macrophage activity and
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T-cell activity could help to determine if there are intrinsic differences in the ability of
different types of goats to respond to infection with C. burnetii.
Limitations of this study include small sample size, lack of information on the
density in which the goats were housed on each farm and self-selection bias through
use of a convenience sample. Low prevalence of C. burnetii infection in the sample limits
the power of this study to detect weak associations. Because of this, the results of this
analysis should be considered as guides for the development of future avenues of
research. Density may be more important than its surrogate factors type of housing and
number of goats in evaluating risk factors for C. burnetii infection. Infected goats kept at
a higher density would result in a greater amount of bacterial contamination per square
meter than infected goats kept at lower densities. The area of the space on each farm
set aside for goat housing was not measured in this study and thus density could not be
calculated. Finally, producers determined whether or not to participate in this study and
also selected which does would be tested in situations where more than 10 eligible does
were present in a herd. The selection bias introduced by this process could have
resulted in overestimation of prevalence if producers with does exhibiting reproductive
events were more likely to volunteer for inclusion in the study than producers owning
herds where reproductive events had not occurred. At the individual level, producers
may have been more likely to select does with a history of reproductive events for
inclusion. This would also result in an overestimation of prevalence and the associations
detected in this study may not be as strong as reported. Random selection of does to be
sampled would have helped to control this bias. C. burnetii is a reportable disease in
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Indiana. Although farm information was recorded by number rather than name to
preserve anonymity, test results were reported to the ISBAH at the zip code and county
level. Reluctance to have results reported may have influenced some producers to
decline participation in this study, resulting in an underestimation of the prevalence of C.
burnetii. Underestimation of prevalence may have led to underestimation of the
strength of the associations reported in this study. In future studies of this nature, it
may be helpful to include a question on reasons for declining participation in order to
better clarify the direction of this bias.
In this study, does living on farms on which cattle, sheep or camelids were present
was associated with decreased odds of testing positive for past exposure to and current
shedding of C. burnetii. This finding was unexpected, but may be due to a dilution effect.
Whether the protective association found in this study could be attributable to a
dilution effect deserves further investigation. The factors influencing C. burnetii
transmission are complex and a full picture of pathogen epidemiology and ecology must
incorporate multiple reservoir and host species within the community of interest,
intrinsic host factors such as immunocompetence and abiotic factors such as wind.
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Reproductive Events
Breed

Age

Cattle, sheep or camelids

C. burnetii

Housing
Herd size
Figure 5-1. Causal diagram illustrating the relationships between the predictors of
interest (red), covariates of interest and infection with C. burnetii.
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Table 5-1. Diagnostic tests and results
Testing Method

ELISA

PCR

Serum

Milk

Vaginal Mucus

Fecal Material

Number Positive

23

9

40

1

Number Negative

590

382

597

578

Total Tested

613

391

637

579
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Table 5-2. Univariate analysis of the predictors of interest. * indicates that 1 was added
to each cell during the analysis in order to estimate the odds ratio
Diagnostic

Positive

Negative

Total

Method

Cattle, sheep
or camelids on
the farm

Reproductive
event on the
farm

Indoor housing

PCR

95% CI

p-value

0.34

0.04-2.55

0.30

0.24

0.07-0.81

0.022

1.15*

0.15-8.81*

0.99

1.14

0.47-2.78

0.74

0.26

0.12-0.58

0.0002

1.06

0.24-4.58

0.94

Odds Ratio
Indoor housing

ELISA

Univariate

Cattle, sheep
or camelids on
the farm

Reproductive

Yes

1

69

70

No

22

514

536

Total

23

583

606

Yes

3

228

231

No

20

362

382

Total

23

590

613

Yes

23

564

587

No

0

26

26

Total

23

590

613

Yes

6

65

71

No

43

530

573

Total

49

595

644

Yes

7

239

246

No

42

366

408

49

605

654

Yes

47

579

626

No

2

26

28

Total

49

605

654

event on the
farm
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Table 5-3. Results for models with seropositivity as the outcome of interest
Predictor

Covariates in model

Odds ratio

95% Confidence

p-value

Interval
Indoor housing
Meat breed
Cattle, sheep or
camelids on the
farm
Meat breed

0.31

0.04-2.33

0.25

0.62

0.24-1.60

0.32

0.23

0.07-0.79

0.020

0.61

0.23-1.57

0.30
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Table 5-4. Results for models with shedding of C. burnetii DNA as the outcome of
interest
Predictor

Covariates in

Odds ratio

model
Indoor housing

95% Confidence

p-value

Interval
0.93

0.39-2.36

0.93

0.36

0.17-0.80

0.012

Cattle, sheep or
camelids on the farm

0.26

0.11-0.58

0.001

Reproductive event
on the farm

0.82

0.18-3.67

0.80

0.25

0.11-0.57

0.001

Meat breed

Cattle, sheep or
camelids on the
farm
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CHAPTER 6.

CONCLUSIONS AND FUTURE DIRECTIONS

6.1

Conclusions

The goal of this project was to establish baseline information about C. burnetii
infection in goats in Indiana. Given that previous studies using serologic techniques
(Sondgeroth et al., 2013; Baker & Pithua, 2014) and outbreak investigations (Bjork et al.,
2014) have established goats as reservoirs for C. burnetii in the United States, the
presence of C. burnetii in goats in Indiana is not unexpected. At the individual level, 3.8%
of does in this sample showed serologic evidence of exposure to C. burnetii. DNA
shedding by at least 1 route was detected in 7.5% of the does in this study. At the farm
level, 11% of the recruited farms had at least one doe with antibodies to C. burnetii.
Twenty percent of the study farms had at least 1 doe test positive for shedding of C.
burnetii DNA. Although these numbers may not seem overwhelming and sample size
limits generalization, based on these numbers 577 of the 2883 farms registered in 2012
may have housed goats shedding C. burnetii. With an infectious aerosol dose of
between 1 and 10 organisms (Oyston & Davies, 2011), C. burnetii in goats presents a
potential public health risk in Indiana.
Although sample size is a limiting factor in generalizing findings about the
geographic distribution of caprine C. burnetii in Indiana, the greater proportion of
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positive animals in PHPD 9 provides a geographic target for future research into C.
burnetii. The use of Cohen’s kappa as a measure of association between serologic and
molecular diagnostic tests was compromised by the low overall prevalence of C. burnetii
infection in Indiana. Given the results of previous experimental and field studies
(Arricau-Bouvery et al., 2003; Rousset et al., 2009), this lack of association is likely a true
finding. Focusing future studies in a geographic area where there is higher prevalence
of infection or utilizing a case-control study design would provide additional support for
this conclusion.
In this study, goats living on farms with cattle, sheep or camelids had a reduction
in the odds of testing positive for C. burnetii. This may be due to the dilution effect. In a
study evaluating the dilution effect in the context of Lyme disease, increased
biodiversity in the environment was found to have a protective effect against human
infection with Borrelia burgdorferi (LoGiudice et al., 2003). Although ticks are considered
to be vectors for C. burnetii and the dilution effect was first explored in the context of
vector borne disease, transmission within domestic ruminant herds and between
ruminants and people is most commonly through inhalation of aerosolized bacteria
rather than by vectors. C. burnetii may act as a density-dependent pathogen where
additional host species decrease the risk of transmission if between species
transmission occurs less frequently than within species transmission, but in order to
clarify this relationship studies involving all potential host species on a given farm are
needed.
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While it is disappointing that genotyping was not effective for a greater number of
samples in this study, identifying ST8 in 3 samples is consistent with the hypothesis that
this sequence type is dominant in goats in the United States (Pearson et al., 2014).
Incorporating culture into the genotyping process may be of use in future studies.
Alternatively, pooled milk samples or pelleting milk solids for use in extraction may help
to increase the concentration of C. burnetii DNA and the likelihood of successful
sequence typing.
6.2

Future directions

Although the focus of these studies was on C. burnetii as an infectious disease in
goats, it cannot be removed from the context of public health. Because of this, there are
2 future directions for this work: research and outreach. Research through a
combination of field and laboratory studies is important because there is still much to
learn about the epidemiology of C. burnetii. Outreach is important because with the lack
of approved vaccinations for animals and the general public in the United States,
prevention and control of C. burnetii infection is dependent upon the knowledge of
veterinarians and physicians and their ability to convey that knowledge to individuals at
risk for exposure to C. burnetii.
In the context of future research, there are also 2 important directions. The first of
these involves investigation of the molecular epidemiology of C. burnetii. Protocols for
rapid sequence typing are available (Hornstra et al., 2011). The use of these could
greatly expand the understanding of C. burnetii in the context of clinical disease, if
sequence typing was attempted on every diagnostic sample testing positive for C.
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burnetii. Both ST20 and ST8 have been identified in bulk tank milk samples from cattle in
Indiana (Bauer et al., 2015), but the small number of samples from goats successfully
sequence typed in this study contributes little to the molecular epidemiology of C.
burnetii in Indiana and no work investigating the prevalence or genotypes of C. burnetii
in sheep in Indiana has been performed. A second route for future research involves
investigating the role of community structure in transmission of C. burnetii. In the
current project, the presence of cattle, sheep and camelids on goat farms resulted in a
decreased odds of does testing positive for both exposure to C. burnetii and shedding of
C. burnetii DNA. Although experimental work evaluating the routes of shedding of C.
burnetii in cattle, goats and sheep has been performed (Rodolakis et al., 2007), no field
studies have been conducted to evaluate infection with C. burnetii in multiple species on
the same farm. Most publications on the role of host species beyond sheep, cattle and
goats in transmission of C. burnetii have been case reports (Pinsky et al., 1991; Stein &
Raoult, 1999). A prospective study including all domestic mammalian species on
multiple farms, the people living and working with them and any external parasites
identified would be very helpful in gaining better understanding of the transmission
cycles of C. burnetii.
Outreach efforts are important to improve detection and treatment of Q fever.
Although 20% of the goat farms in this study had at least 1 doe shedding C. burnetii, Q
fever appears to be an uncommon diagnosis in Indiana (McQuiston et al., 2006; Beall et
al., 2007). Nevertheless, increasing veterinarian and physician awareness of C. burnetii
in Indiana could serve to improve diagnosis and reporting of Q fever. This would
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enhance the effectiveness of passive surveillance system currently used for Q fever
reporting in Indiana. In addition to focusing outreach and educational efforts on medical
professionals, increasing producer awareness of Q fever would be beneficial. Educating
producers about C. burnetii would allow them to protect their own health through the
use of personal protective equipment. Awareness of Q fever may also encourage
producers to seek medical treatment if they develop an influenza-like illness. PHPD 9
may be a good place in Indiana to develop and pilot test programs aimed at educating
producers about the risks of infection with C. burnetii and the actions that they can take
to protect themselves.
Q fever is a disease that the people and animals of Indiana will be living with for a
long time. The studies comprising this project have laid a foundation for understanding
C. burnetii in Indiana, but it is certainly not a completed process. Other species,
including but not limited to sheep, camelids and people needed to be included in the
structure that may eventually encompass the complete epidemiology of C. burnetii in
Indiana.
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Appendix A: E-mail recruitment letter
Dear Goat Owner,
I am a graduate student at Purdue studying a disease called Q fever and its
presence in Indiana. Q fever is a disease of ruminants (goats, sheep and cattle) and
humans. In ruminants the primary sign of Q fever is abortion. In people it can cause a
flu-like illness, pregnancy loss in women and in some cases long term heart problems or
chronic fatigue syndrome. Coxiella burnetii, the Q fever bacterium, is shed in
reproductive discharges, milk, feces and urine. Humans are exposed to Q fever through
inhaling or ingesting bacteria from these sources.
I would like to determine the prevalence of Q fever in goats in Indiana. In order
to do this, I hope to collect samples of blood to test for previous exposure to Q fever
and milk, vaginal swabs and feces to check for active shedding of bacteria. I will be
sampling from up to 10 does over 1 year of age per farm, excluding pregnant does. In
addition, I would like to evaluate risk factors for Q fever. Evaluating risk factors involves
completing one survey on farm and management practices and a second survey for data
about each animal that we sample such as age, breed, reproductive history, etc.
Your information will remain confidential. At the time of enrollment in the study,
you will receive a farm identification number and each doe will receive an animal
identification number. Any information that we publish will be based on the county,
region (northern, central or southern) and the state of Indiana. Individual farm names
and locations will not be disclosed. You may choose to learn the test results of your
animals, but you are not obliged to. If you choose to learn the test results, you can
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contact me via telephone or e-mail and provide me with your farm identification
number. Test results will only be identified by this number. You can choose to
withdraw from the study at any time without penalty.
Our goal is to gain basic information on the prevalence and distribution of Q
fever in Indiana while protecting producer confidentiality. If you would be interested in
participating in this study or have additional questions, please contact me at
bauer20@purdue.edu.
Sincerely,
Dr. Amy Bauer
Graduate Student
Department of Comparative Pathobiology
Purdue University
College of Veterinary Medicine
West Lafayette, IN 47904
bauer20@purdue.edu
(765)494-2294
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Appendix B: Animal history survey

Animal Sample Form (Fill out 1 form for each animal sampled)
1. Date

_______/________/2014

2. Farm ID (match Farm Survey)

_____________________

3. Animal ID (Farm ID –Animal ID) _____________________
4. Breed (circle one – should be just for the animal being sampled)
a. Alpine
b. LaMancha
c. Nubian
d. Toggenburg
e. Saanen
f. Oberhasli
g. Sable
h. Nigerian Dwarf
i.

Other _______________________________________

5. Age __________________ Years
6. Most recent kidding? (Month) ___________________________
7. How many times has she kidded? _________________________________
8. Any history of abortion with this goat?
Yes

No

a. If yes, what year(s)? ____________
b. Was a diagnosis made?
Yes

No

c. What was the diagnosis?_____________________________________
9. Any history of stillbirth with this goat?
Yes

No
a. If yes, what year(s)?
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b. Was a diagnosis made?
Yes

No
c. What was the diagnosis?______________________________________

10. Any history of weak kids with this goat?
Yes

No
a. If yes, what year(s)? ____________
b. Was a diagnosis made?
Yes

No

c. What was the diagnosis?______________________________________

11. Any history of resorption with this goat?
Yes

No
a. If yes, what year(s)? ____________
b. Was a diagnosis made?
Yes

No

c. What was the diagnosis?______________________________________
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Appendix C: Farm information survey:
Indiana Goat Owner Survey
1. Date

_________/_________/2014

2. Farm ID ____________________________
3. Farm Zip code ________________________
4. Farm County _________________________
5. No. Animals Sampled __________________
6. Location of Interview
a. Farm____________________________
b. Fair _____________________________
c. Other ___________________________
7. How long have you owned your farm? ___________ years
8. For how many years have you owned goats? _____________
9. How many goats do you own? _______________
a. Number of bucks:

___________________

b. Number of wethers: ___________________
c. Number of does:

___________________

10. How many different breeds do you have? ______________
11. What breeds are they (dairy, meat or other – circle all that apply)?
a. Alpine
b. LaMancha
c. Nubian
d. Toggenburg
e. Saanen
f. Oberhasli
g. Sable
h. Nigerian Dwarf
i.

Other Dairy Breed _______________________________________
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j.

Boer Meat

k. Kiko Meat
l.

Tennessee/Fainting/Myotonic

m. Spanish Meat
n. Other Meat Breed ____________________________________________
12. What do you use the goats for?
a. Meat

Yes

No

b. Pasteurized Milk

Yes

No

c. Pasteurized Cheese

Yes

No

i. What type(s) of cheese ____________________
d. Raw Milk

Yes

No

i. For animal consumption

Yes

No

ii. For human consumption

Yes

No

Yes

No

e. Raw Cheese

i. What type(s) of cheese ____________________
f. Soap

Yes

No

g. Companions/Pets

Yes

No

h. Showing or 4-H

Yes

No

i.

Other _____________________________________

13. Do you own other animals?

Yes

No

a. Sheep

Yes

No

b. Cattle

Yes

No

Yes

No

c. Alpaca/llamas

Yes

No

d. Cats

Yes

No

e. Dogs

Yes

No

f. Horses

Yes

No

g. Chickens

Yes

No

i. If yes, are these dairy cattle?

h. Other ________________________________________
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14. Are you the person who primarily takes care of the goats?

Yes

No

15. Do you have non-family employees that work with the goats?

Yes

No

a. How many? ____________
b. Do they have goats of their own?

Yes

No

16. Have you ever experienced abortions in your goats?

Don’t know
Yes

No

a. If yes, in which year were the most recent abortions? _____________
b. How many aborted at that time? ________________
c. Was a diagnosis made?

Yes

No

d. What was the diagnosis?
__________________________________________
e. How do you dispose of the abortive material [how is it handled (gloves,
hands, shovel) and where does it go]?
____________________________________________________________
____________________________________________________________
____________________________________________________________
____________________________________
17. Have you ever experienced abortions in your sheep?

Yes

No

a. If yes, in which year were the most recent abortions? _____________
b. How many aborted at that time? ________________
c. Was a diagnosis made?

Yes

No

d. What was the diagnosis?
__________________________________________
e. How do you dispose of the abortive material [how is it handled (gloves,
hands, shovel) and where does it go]?
____________________________________________________________
____________________________________________________________
____________________________________________________________
____________________________________
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18. Have you ever experienced abortions in your cattle?

Yes

No

a. If yes, in which year were the most recent abortions? _____________
b. How many aborted at that time? ________________
c. Was a diagnosis made?

Yes

No

d. What was the diagnosis?
__________________________________________
e. How do you dispose of the abortive material [how is it handled (gloves,
hands, shovel) and where does it go]?
____________________________________________________________
____________________________________________________________
____________________________________________________________
____________________________________
19. Have you ever experienced stillbirths in your goats?

Yes

No

a. If yes, in which year were the most recent stillbirths? _____________
b. How many stillbirths occurred at that time? ________________
c. Was a diagnosis made?

Yes

No

d. What was the diagnosis?
__________________________________________
e. How do you dispose of the stillborn material [how is it handled (gloves,
hands, shovel) and where does it go]?
____________________________________________________________
____________________________________________________________
____________________________________________________________
____________________________________
20. Have you ever experienced stillbirths in your sheep?

Yes

No

a. If yes, in which year were the most recent stillbirths? _____________
b. How many stillbirths occurred at that time? ________________
c. Was a diagnosis made?

Yes

No
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d. What was the diagnosis?
__________________________________________
e. How do you dispose of the stillborn material [how is it handled (gloves,
hands, shovel) and where does it go]?
____________________________________________________________
____________________________________________________________
____________________________________________________________
____________________________________
21. Have you ever experienced stillbirths in your cattle?

Yes

No

a. If yes, in which year were the most recent stillbirths? _____________
b. How many stillbirths occurred at that time? ________________
c. Was a diagnosis made?

Yes

No

d. What was the diagnosis?
__________________________________________
e. How do you dispose of the stillborn material [how is it handled (gloves,
hands, shovel) and where does it go]?
____________________________________________________________
____________________________________________________________
____________________________________________________________
____________________________________
22. Have you ever had weak kids from your goats?

Yes

No

a. If yes, in which year were the most recent weak kids born?
____________
b. How many weak kids were born at that time?
_______________________
c. How many weak kids survived?
___________________________________
d. Was a diagnosis made?

Yes

No
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e. What was the diagnosis?
________________________________________
f. How were any kids that died disposed of?

23. Have you ever had weak lambs from your sheep?

Yes

No

a. If yes, in which year were the most recent weak lambs born?
____________
b. How many weak lambs were born at that time?
_______________________
c. How many weak lambs survived?
___________________________________
d. Was a diagnosis made?

Yes

No

e. What was the diagnosis?
________________________________________
How were any lambs that died disposed of?

24. Have you ever had weak calves from your cattle?

Yes

No

a. If yes, in which year were the most recent weak calves born?
____________
b. How many weak calves were born at that time?
_______________________
c. How many weak calves survived?
___________________________________
d. Was a diagnosis made?
e. What was the diagnosis?
________________________________________

Yes

No
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f. How were any calves that died disposed of?
____________________________________________________________
____________________________________________________________
________________________
25. Have you ever had any pregnancies resorbed in your goats?

Yes

No

a. If yes, in which year were the most recent resorptions?
________________
b. How many resorptions occurred at that time?
________________________
c. Was a diagnosis made?

Yes

No

d. If yes, what was the diagnosis?
___________________________________
e. Have you been able to breed the doe(s) successfully since this time? Yes
No
26. Have you ever had any pregnancies resorbed in your sheep?

Yes

No

a. If yes, in which year were the most recent resorptions?
________________
b. How many resorptions occurred at that time?
________________________
c. Was a diagnosis made?

Yes

No

d. If yes, what was the diagnosis?
___________________________________
e. Have you been able to breed the ewe(s) successfully since this time? Yes
No
27. Have you ever had any pregnancies resorbed in your cattle?
a. If yes, in which year were the most recent resorptions?
________________
b. How many resorptions occurred at that time?
________________________

Yes

No
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c. Was a diagnosis made?

Yes

No

d. If yes, what was the diagnosis?
___________________________________
e. Have you been able to breed the cow(s) successfully since this time? Yes
No
28. How do you breed your goats?
a. Natural – goats on premises

Yes

No

b. Natural – non-owned goats

Yes

No

i. Does taken to bucks

Yes

No

ii. Bucks brought to does

Yes

No

c. Artificial Insemination – goats on premises Yes

No

d. Artificial Insemination – non-owned goats

No

e. I don’t breed my goats

Yes

Yes No

29. How many kids were born in the most recent season? _________
30. How many new goats from outside sources are introduced to the farm per year
on average for new stock, breeding, etc.? ____________
31. Are new goats obtained from:
a. Births from goats on the farm
b. Purchases at shows/fairs
c. Purchases from other breeders within the county
d. Purchases from other breeders within Indiana
e. Purchases from out-of-state breeders
32. Do you ever board your goats at another facility?

Yes

No

33. Do you board sheep, cattle or goats for others?

Yes

No

a. Do you take specific hygienic precautions when milking?
b. What precautions do you take (mark all that apply)?
i. Clean the teats prior to milking
ii. Pre-dip teats
iii. Post-dip teats

Yes

No
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iv. Location specific for milking
v. Other
__________________________________________________
__________________________________________________
__________________________________________________
_____________________________________________
c. Where are your goats housed?
a. Mostly indoors
b. Mostly outdoors
c. Even split between indoors and outdoors
d. What are the goats flooring indoors made of?
a. Dirt
b. Concrete
c. Other _____________________________________
e. How often do you clean the goats bedding?
a. Less than 1x/month
b. Monthly
c. Every two weeks
d. Weekly
e. Daily
f. How do you dispose of the litter?
__________________________________________________________________
__________________________________________________________________
_______________________

g. Do you use any of the following to clean the stalls?
a. Detergents such as soap

Yes

No

b. Disinfectants such as bleach

Yes

No

c. Just water

Yes

No
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d. Do not use anything

Yes

No

h. Do you use any pressure washers?

Yes

No

i.

Do your goats have contact with sheep, goats or cattle on adjacent farms?
Yes

j.

No

Are there farms adjacent to your property with sheep, goats or cattle?
Yes

No

Don’t Know

a. How many farms? _____________
b. If yes, what type of farms?
i. Sheep
ii. Goats
iii. Cattle
k. Do you know if there are non-adjacent, nearby (within 1 mile) farms with
sheep, goats or cattle?
Yes

No

Don’t Know

a. How many farms? _____________
b. If yes, what type of farms?
i. Sheep
ii. Goats
iii. Cattle
l.

How often do your animals see a veterinarian?
a. Regularly – yearly
b. Regularly – 2x/ year
c. Regularly – 3x/year
d. Regularly - Quarterly
e. Regularly - Weekly
f. As needed
g. Never
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m. What is your veterinarian’s primary area of practice?
a. Small animal medicine
b. Food animal medicine
c. Equine medicine
d. Goat/Small ruminant medicine
e. Mixed practice
f. Uncertain
n. Do you routinely deparasitize your goats?

Yes

No

a. If yes, what do you use (list all)?
_______________________________
b. How often do you use it?
i. Monthly
ii. Every other month
iii. Quarterly
iv. 3x/year
v. 2x/year
vi. Annually
vii. As needed
viii. Never
o. Do you take any of the following precautions when working with goats:
a. Wear gloves

Yes

No

b. Wear coveralls that you remove before going home

Yes

No

c. Wear a face mask

Yes

No

d. Wear goggles

Yes

No

p. Do you take any of the following precautions when visiting another farm
with goats:
a. Wear gloves

Yes

No

b. Wear coveralls that you remove before going home

Yes

No

c. Wear a respirator/surgical mask

Yes

No
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d. Wear eye protection
q. Do you routinely attend the births of your goats?

Yes

No

Yes

No

a. If yes, do you take any precautions when attending the births?
i. Wear gloves

Yes

No

ii. Wear dedicated coveralls

Yes

No

iii. Wear a surgical mask

Yes

No

iv. Wear a respirator

Yes

No

v. Wear eye protection

Yes

No

vi. Other
__________________________________________________
r. Have you or someone in your family or employee ever gotten a flu-like
illness during a kidding season?

Yes

No

a. If yes, was it diagnosed?

Yes

No

b. Diagnosis: _________________________________________
s. Do you ever consume raw milk from your goat(s)?
Yes

No

Rarely

If answer to 50 is Yes:
a. For how many years have you been consuming raw milk?
___________
b. On average, how much do you consume a day?
__________________
c. On average, how much does your family consume a day?
_____________
d. Do you also consume raw cow milk?

Yes

No

e. Do you acquire raw milk from any other location?

Yes

No

Where?
i. Store
ii. Neighbor
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iii. Other
__________________________________________________
f. What is the primary reason for why you consume raw milk?
i. Taste

Yes

No

ii. Allergies

Yes

No

iii. Convenience

Yes

No

iv. Health

Yes

No

v. Other:_____________________________________________
______________________________________________________
If answer to 50 is No:
g. What is the primary reason for why you do not consume raw milk?
________________________________________________________
________________________________________________________
________
t. Do you ever consume pasteurized milk from your goat(s)?

Yes

No

Yes

No

a. What method do you use to pasteurize milk?
i. Vat pasteurization (30 minutes 145oF/63oC)

ii. High temperature short time (15 seconds 161oF/72oC)
Yes

No

iii. Ultra Pasteurization (2.0 seconds 280oF/138oC)
Yes

No

iv. Other:
Equipment: ____________________________________________
Temperature: ____________
Duration: _____________________

u. Do you think there are risks to people associated with owning goats?
Yes

No
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If yes, what are some of those risks?
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
53. Do you know of any diseases that can cause abortions in goats?
Yes

No

If yes, can you tell me what some of those diseases are?
Yes

No

________________________________________
________________________________________
________________________________________
________________________________________
v. Do goats carry any diseases that can be transmitted to people?
Yes

No

If yes, Can you tell me what some of those diseases are?
Yes

No

_______________________________________
_______________________________________
_______________________________________
_______________________________________
_______________________________________
55. Before speaking with us had you ever heard of a disease called Q-fever that
is caused by a bacterium called Coxiella burnetii?
If yes, do you know if it can be transmitted to people?
Yes it can be transmitted to people
No it cannot be transmitted to people
I don’t know

Yes

No
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If it can be transmitted to people, how are people most likely to get the
disease?
______________________________________________________
______________________________________________________
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